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ABSTRACT
Objectives: The objective of this thesis was to evaluate and compare
neuromuscular system function in a group of young, healthy old and mobilityimpaired older females (gait speed less than 1m/s) in an attempt to identify which
neuromuscular factors contribute most to the loss of mobility and functional
performance with age.
Methods: The ankle dorsiflexor and knee extensor muscles were used as a model in
these studies. First, in Chapter 2 quantitative electromyography (EMG) was used to
evaluate motor unit (MU) numbers, properties and the fidelity of the neuromuscular
junction. Next, Chapter 3 conducted magnetic resonance imaging (MRI) to examine
contractile and non-contractile muscle components, as well as a novel technique
known as magnetization transfers (MT) to assess muscle protein quality. Finally, to
determine how changes in the neuromuscular system result in impaired mobility
and a decline in functional performance, Chapter 4 explored isometric muscle
strength, power and velocity of muscular contraction in the lower extremity muscle
groups.
Results: Mobility impaired older adults had significantly lower motor unit number
estimates (MUNE) in the tibialis anterior (TA) than young adults (Chapter 2). In the
ankle dorsiflexor and knee extensor muscles the proportion of non-contractile
muscle tissue in both healthy and mobility-impaired older adults was approximately
twice that of young adults (Chapter 3). Additionally, muscle protein quality, as
determined via the magnetization transfer ratio (MTR) was significantly reduced in
both groups of older adults compared to young, and further reduced in healthy old
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compared to mobility impaired adults (Chapter 3). While isometric strength was
maintained in the ankle dorsiflexor muscles of older adults, muscular power was
significantly reduced in mobility-impaired, but not healthy older adults (Chapter 4).
Muscle contraction velocity was determined to be the critical component in power
production, and was significantly reduced in the knee extensor muscles of mobility
impaired older adults compared to young and healthy older adults (Chapter 4).
Significance: This thesis provides novel information regarding the neuromuscular
factors that contribute to the loss of mobility with age. It highlights the importance
of power and muscle contraction velocity for sustaining lower extremity functional
performance with advanced age. These studies provide insight into important
outcomes that can be used for further research to help maintain mobility into old
age.

Keywords: Aging, mobility, motor unit, power, magnetic resonance imaging (MRI),
electromyography (EMG)
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SUMMARY FOR LAY AUDIENCE
The purpose of this research was to compare nerve and muscle health in
young adults, healthy older adults and older adults with impaired mobility. We
identified mobility impairment as older adults who walked slower than 1 m/s. The
aim of this thesis was to identify factors that may contribute to the loss of mobility
with age. To accomplish this we conducted three experiments to: 1) record the
electrical activity that comes from muscle during normal muscle contraction, 2) use
magnetic resonance imaging (MRI) to image muscles and compare their
composition and 3) record measures of strength, power and performance in the
lower extremity. We found that older adults with mobility impairment had reduced
nerves supplying a muscle in the lower leg compared to young adults. Using MRI we
also discovered that both groups of older adults had a greater proportion of fat
within their muscles and poorer quality of muscle protein compared to young
adults. Finally, we found that muscle power, which is calculated by multiplying force
by angular velocity of contraction, declined more than strength with age.
Specifically, we revealed that the velocity of muscle contraction seems to be the
critical factor leading to the loss of power in older adult’s muscles, and that those
with mobility impairment had the greatest loss of muscle contraction velocity. These
findings are important because they highlight some of the adaptations to nerve and
muscle that occur with aging and lead to impairment in older adult’s mobility. The
results of this thesis provide important outcome measures that can be used to
design programs aimed to maintain mobility in older adults.
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Chapter 1
GENERAL INTRODUCTION AND OVERVIEW

1.0 General Introduction
1.0.1 The aging population
It has been well documented that the Canadian population has been rapidly
aging. Based on the 2019 census from Statistics Canada, 1 in 6 (17.5%) of Canadians
are over the age of 65 [1]. Statistics Canada also reports that the rate of growth of
persons over the age of 65 (3.7%) is more than double the growth of the overall
population (1.4%). Based on their projections, the number of adults over 65 will
continue to increase in the coming years, reaching as high as 20% by 2025 and 25%
by 2059. Additionally, due to advancements in technology and healthcare, people
are living longer than ever [1]. Research has consistently shown that the very old
(80+ years) exhibit even greater losses of strength [2, 3], power [4], gait velocity [3,
4] and functional performance [5] compared to the old (65-79 years), leading to a
greater prevalence of mobility impairment with advancing age. With similar trends
being projected globally [6], research focused on the maintenance of health and
mobility with advanced age is paramount.
1.0.2 Aging and mobility
As a person ages their mobility tends to be reduced. Mobility is important for
our health not only from a physical perspective, but also psychologically, as reduced
mobility may lead to lack of engagement, social isolation and overall loss of
independence [7]. Reduced gait velocity is one of the most commonly reported
1

mobility impairments in the literature [8-10]. Most researchers agree that a gait
velocity of less than 1 m/s represents a critical threshold for mobility, below which
subjects are categorized as having mobility impairment or “mobility disability”[1113] and are at increased risk of complication related to their mobility impairment. It
has been reported that self-selected walking speed demonstrates a precipitous
decline in the 6th decade [14], and research has shown older adults with reduced
mobility have an increased risk of mortality [15]. For the purposes of this
dissertation, individuals with a gait velocity of less than 1 m/s will be referred to as
mobility-impaired.
Some other alterations to gait and mobility with age include decreased step
length [16], increased time spent in double support [9, 17] and co-contraction of
agonist/antagonist muscles during locomotion [10, 18]. Although some of these
variations in gait may be explained by a loss of muscular strength with aging [16,
17], it is feasible that all of these alterations to aged gait aim to increase the stability
of walking [9, 10, 16]. Gait is an innately unsteady activity, and it is reasonable to
suggest that as a person ages they may alter their walking pattern to improve
stability and mitigate risk of falls. Falling is a significant health concern for older
adults and it has been estimated that over $2 billion in annual healthcare costs are
associated with falls and fall-related injuries [7]. Studies have shown that older
adults with mobility impairments are twice as likely to fall as similarly aged adults
[19], thus a better understanding of mobility impairment with age, and the factors
that contribute to it, may help to improve physical well-being in older adults and
reduce healthcare costs associated with falls.
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1.0.3 Sarcopenia
It is well established that the natural process of aging leads to the loss of
muscle mass and an accompanying loss of strength. This process, which is known as
sarcopenia, was first described in 1989 by Irwin Rosenberg [20]. There are several
factors which contribute to the development of sarcopenia with age including
disruption of excitation-contraction coupling, inadequate protein intake, altered
endocrine function, physical inactivity, genetic predisposition and degeneration of
the neuromuscular system [21, 22]. Together, these contribute to the loss of muscle
mass and concomitant loss of strength in older adults with sarcopenia. However, in
the years following the publication of Rosenberg’s seminal paper, researchers
discovered that although there is a loss of muscle strength with age, there is an even
greater loss of muscular power. Muscle power is the product of torque and velocity
of muscle contraction. As both torque production and velocity of muscle contraction
are independently attenuated as a person ages, their combined effect on power
production may be greater than the individual contribution of either component
[23]. A study by Skelton and colleagues [5] found that strength in the knee extensors
declined at a rate of 1.5% per year in adults over 65 years, whereas knee extensor
power declined twice as quickly (3.5% per year). This accelerated loss of muscle
power has been theorized to be the result of the selective loss of type II fibers in the
skeletal muscle. Due to their larger innervation ratio and relative lack of oxidative
enzymes, type II motor neurons may be more susceptible to oxidative stress and
chronic inflammation associated with typical aging [24-27]. If indeed the largest,
fastest contracting type II muscle fibers are preferentially lost with age, it would
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cause a slowing of whole muscle contractile velocity, and explain the accelerated
loss of muscle power demonstrated in the study by Skelton et al. [5] and many
others [28-30]. It would also indicate that muscle power, rather than muscle mass
or strength, may be a more sensitive measure of degeneration and subsequent
neuromuscular remodeling with age.
Strictly speaking, sarcopenia refers to the loss of muscle mass with age. [20]
However, evidence suggests that even preserved muscle mass does not eliminate
the weakness observed in older adults [31]. This has led some to investigate new
ways to characterize aged muscle. Clark and Manini [32] have asserted that the loss
of muscle mass (i.e., sarcopenia) is inadequate to describe the complexity of the
aging process in muscle and have suggested a new term, dynapenia, to describe the
alteration in contractile properties and neurological function that occurs with age,
leading to the loss of strength and power. Muscle quality has also been described as
a more robust measure of skeletal muscle aging. Muscle quality refers to the
strength per cross-sectional area (CSA) of muscle tissues and represents the
intrinsic force-generating capacity of a muscle [21]. A study by McNeil and
colleagues [33] used magnetic resonance imaging (MRI) to determine muscle CSA
and found that there was no relationship between strength and amount of muscle
tissue in the dorsiflexors of young compared to older adults. This supports the
assumption that there is an age-related decrease in the intrinsic force generation of
individual muscle fibers (i.e., muscle quality) that leads to reduced strength and
function with age, rather than being the product of the quantity of muscle mass
alone. Although there are numerous factors that may affect muscle quality (for a
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review see Doherty[21]), there is ample evidence to suggest that changes in the
neuromuscular system play a pivotal role in reduced muscle quality with age and
will be the focus of this dissertation.
1.0.4 Magnetic resonance imaging
MRI is a noninvasive imaging technique that uses strong magnetic fields paired
with radio frequency (RF) waves to provide contrast and visualize soft tissues
within the human body [34-36]. MRIs are based on the principle of nuclear magnetic
resonance, where protons within the nuclei of atoms spin, or precess, in a particular
alignment when exposed to a magnetic field [34]. These protons behave like tiny
magnets that are randomly oriented at rest, but align themselves in the direction of
an external magnetic field, such as that created inside an MRI scanner. There are
two positions in which protons can align within a magnetic field: parallel and antiparallel. Since parallel is a lower energy state, slightly more protons will tend to
align in the parallel position creating a net magnetization in the longitudinal
direction [34]. When a RF pulse with the same frequency as the precessing protons
is delivered, some of the energy is absorbed by the protons and they move from the
parallel position into an orthogonal position, reducing net longitudinal
magnetization [34]. At the same time, the RF pulse causes the precessing protons to
synchronize, creating a new transverse magnetization. When the RF pulse is turned
off, longitudinal magnetization returns as protons drop back from the high-energy
state to the low-energy state. This is known as longitudinal relaxation time, and is
represented by the time constant T1 [34]. Additionally, protons lose their precession
coherence and transversal magnetization disappears, which is known as transversal
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relaxation and is represented by time constant T2 [34]. T1 and T2 are inherent
properties of biological tissues and vary with the type of tissue. Using the innate
difference in T1 and T2 in different tissues, MRI is able to create contrast to visualize
structures within the body. Fluids and water tend to have a longer T1 time (>1000
ms), whereas fats have a shorter T1 (<200 ms) [36].
Using this technology, researchers are able to use the inherent variability in
T1/T2 between fluids and fats to image muscle in vivo and determine CSA and
volume of muscle tissue. Following motor neuron loss and subsequent muscle
atrophy with age, there is a decrease in contractile muscle mass as fat and
connective tissue replace atrophied muscle fibers [37-39]. To improve upon
traditional measurement of muscle CSA, some studies began to separate noncontractile tissue from contractile tissue to determine total contractile muscle mass
[37, 40, 41]. This allowed researchers to better account for the infiltration of fats
and connective tissue into the muscle. Although this technique helps to normalize
strength measurements (strength/contractile muscle mass), it is inadequate to
determine the changes to intrinsic muscle force generation. Though it is possible to
determine intrinsic muscle composition through muscle biopsies [42, 43], it is
invasive for participants and results from muscle biopsy studies remain
inconclusive [44-46]. Thus, researchers continued to pursue a noninvasive measure
to assess the contents and quality of muscle protein.
1.0.5 Magnetization transfer
As discussed above, MRI uses strong magnetic fields to align protons within
human tissues. Conventional MRI only affects “free” water protons; it is unable to
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detect protons attached to proteins and other macromolecules because their T2 is
too short (<1ms) [47, 48]. Protons in these macromolecules can, however, affect the
spin state of the “free” water protons. Therefore, by applying an off-resonance RF
pulse, the MR technician can saturate protons in large macromolecules to create
additional contrast on MRI known as magnetization transfer (MT) (for a review see
Henkelman et al. [47]). A magnetization transfer ratio (MTR) can then be
determined by subtracting the MR images with off-resonance pre-saturation RF
pulse (M1) by images without (M0) then dividing that number by M0 (Equation
1)[49]
Equation 1:
MTR = (M0 – M1)
M0
MT was first used clinically to track white matter myelination primarily in
multiple sclerosis [50, 51], but has since been adopted in many other clinical
settings including being used to assess skeletal muscle quality. In skeletal muscle
with higher protein content, MTR will be larger as proteins will be more greatly
affected by the pre-saturation MT pulse. A lower MTR indicates decreased exchange
of magnetization between “free” protons and protons bound to macromolecules
(such as protein), and therefore, indicates a reduction in the quantity and quality of
muscle protein [41, 49]. Using this technique, a recent paper by Power et al. [41]
was able to identify reductions in MTR in the tibialis anterior (TA) of older adults
compared to healthy young controls.
1.0.6 The motor unit and motor unit loss
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A motor unit consists of a single motor neuron (located in the anterior or
ventral horn of the spinal cord grey matter) and all of the muscle fibers innervated
by its peripheral axon. The motor unit (MU) is regarded as the fundamental
component of the motor system and the “final common pathway” for muscle
activation and motor control [52]. It is responsible for all voluntary and autonomic
muscle contraction. There is abundant research demonstrating that motor units are
lost with age [2, 21, 28, 53-56], leading to reduced muscle mass, strength, power,
and an overall decline in mobility in older adults. However, although there is
evidence of significant MU loss after the age of about 60, strength is usually well
maintained until much later in life [2]. This is, in part, due to the process of collateral
reinnervation. As a motor neuron dies, its peripheral axon “dies back” toward the
soma in the spinal cord [26]. This leaves muscle fibers previously innervated by that
axon dennervated and unable to contribute to muscle contractions. Without trophic
influences from the motor neuron, these muscle fibers will atrophy and die. Under
normal circumstances, a neighboring motor axon will sense that these muscle fibers
have been orphaned and sprout a collateral axonal branch to re-innervate these
muscle fibers (Figure 1.1) [57]. Thus, much of the early MU loss in a muscle is
masked through the process of collateral reinnervation. Importantly, as muscle
fibers become innervated by a new axonal branch, they will begin to take on the
characteristics of their new parent motor neuron. This is supported in the literature
by evidence of increased co-expression of myosin heavy chain (MHC) isoforms MHC
I and MHC IIA [58] as well as type I fiber grouping in aged muscle [21]. Therefore, as
the larger, faster conducting type II motor neurons die off, the MU pool begins to
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shift towards more type I slow twitch muscle fibers and muscles begin to lose the
ability to produce rapid, high force contractions. This is why muscle peak power
generating capabilities may be a more sensitive measure of neuromuscular
degeneration and subsequent remodeling than muscle mass or strength. However,
there is a limited capacity for collateral reinnervation, and eventually continued
motor unit loss outpaces the reinnervation of muscle fibers leading to the loss of
muscle mass observed in sarcopenia [59].
Conventional measures to detect sarcopenia in older adults, such as
circumferential measurement of muscle mass or reduced strength, are unable to
detect the reorganization of the neuromuscular system by collateral reinnervation.
Thus, they are unable to detect changes in muscle until a critical threshold of MU
loss has occurred [2]. This led to the demand to develop new techniques to measure
MU loss and sarcopenia before it had manifested in reduced muscle mass and
strength.
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Figure 1.1. Collateral Reinnervation
(A) Depicts a cross-section of two motor neurons (MN) in the anterior horn cell of
the spinal cord, and the muscle fibers they innervate comprising a motor unit (MU).
(B) With age, axonal damage causes axons of some MNs to “die-back” towards the
soma. This leaves muscle fibers associated with that axon dennervated and unable
to contribute to muscle contractions. (C) Under normal circumstances, the surviving
MN will sense that these muscle fibers have been dennervated, and sprout a
collateral axon to reinnervate most of the orphaned muscle fibers. Importantly,
muscle fibers reinnervated by a collateral axon will begin to demonstrate
characteristics similar to their new parent neuron. Thus, through this compensatory
process there is an increase in the average size of MUs and a shift towards a more
homogenous MU pool. (Modified from Stalberg, E, Falck, B. The role of
electromyography in neurology. Electroencephalogr Clin Neurophysiol. 1997; 103:
579-98) [57]
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1.0.7 Motor unit number estimation
Nerve conduction studies and needle electromyography (EMG) are traditional
neurophysiological diagnostic techniques, which are the foundation of clinical
neurophysiology. Although these techniques are able to provide evidence of MU loss
(in the form of reduced nerve conduction velocity, and increased MU action
potential duration), they are unable to quantitatively determine the amount of
motor axon loss in a muscle. In 1971, McComas and colleagues [60] described an
innovative technique to estimate the number of motor units within a muscle. This
technique was later named motor unit number estimation (MUNE) and has
provided an avenue for intensive research into many different neuromuscular
pathologies including post-polio syndrome [61], amyotrophic lateral sclerosis (ALS)
[62, 63], diabetic polyneuropathy [64], peripheral neuropathy [65] as well as
changes in the neuromuscular system with normal aging [2, 28, 56].
MUNE is a quantitative electrophysiological technique that uses surface or
needle EMG to estimate the number of functioning MUs in a muscle. In the years
following the publication of the groundbreaking paper by McComas and colleagues
[60], many different MUNE techniques have been developed; however, they are all
based around the same underlying principle. The maximal compound muscle action
potential (CMAP) of the muscle under study is divided by the average surfacedetected motor unit potential (S-MUP) size metric to determine the MUNE
(Equation 2) [66, 67].
Equation 2:
MUNE = maximal CMAP amplitude
mean S-MUP amplitude
11

The CMAP is an evoked response by a supramaximal stimulation to the motor
nerve supplying the muscle (or muscle group) and represents the combined
activation of all the MUs in that muscle. The S-MUP, on the other hand, represents
the electrical representation of the size of a single motor neuron and all the muscle
fibers it innervates. Therefore, by dividing the size of the entire motor unit pool by
the average size of a sample of individual MUs an estimate of the number of MUs in
that muscle or muscle group is derived [66, 67].
1.0.8 Motor unit number estimation techniques
Different MUNE techniques vary in how the average S-MUP size is determined,
each with their own inherent advantages and disadvantages. Among the most
commonly used MUNE techniques are incremental stimulation, multiple point
stimulation (MPS), the statistical method and spike-triggered averaging (STA) (For a
review see Gooch et al. [67]). Incremental stimulation, MPS and the statistical
method all rely on delivering an electrical stimulus to the motor nerve of the muscle
under study. This, therefore, confines these techniques to muscle with large sections
of their motor nerve available superficially for external stimulation, which tends to
be smaller more distal extremity muscles [67]. STA, on the other hand, uses a
combination of both needle and surface EMG to collect a sample of S-MUPs from a
muscle during a moderate intensity muscle contraction [68, 69]. This allows STA to
be applied to any muscle from which a valid CMAP can be measured.
1.0.9 Spike-triggered averaging
Traditional STA uses both needle and surface EMG to determine a quantitative
EMG measurement. During a moderate intensity voluntary contraction, the
12

concentric needle electrode detects action potential impulses within the muscle.
These impulses are measured and summated to produce a motor unit potential
(MUP) [70]. While the needle EMG is assessing MUPs from within the muscle fibers,
surface electrodes are concurrently recording EMG signals from the surface of the
muscle (S-MUPs). A window-based discriminator is then used to isolate one of the
MUPs from the EMG interference pattern. The individual MUP is used as a trigger
and time locked to the surface EMG signal, allowing for the extraction of the surface
EMG signal that is representative of the needled-detected MUP [69, 71, 72]. By
measuring multiple surface detected potentials from MUPs at different depths
and/or orientations of needle electrode insertion into the muscle, a representative
sample of S-MUPs can be determined. The average S-MUP size is then calculated
from this sample and inserted into the equation (Equation 2) to determine a MUNE
[69, 71].
The main advantage of STA over some of the other conventional MUNE
measurements is that STA does not rely on large sections of peripheral nerve being
available for stimulation. This allows STA to be applied to larger more proximal
muscles (i.e. biceps brachii, vastus medialis/lateralis, upper trapezius). Additionally,
STA records electrical activity coming from the muscles during a voluntary
contraction (as opposed to externally stimulated via the motor axon), which is a
more practical approach and better represents how the neuromuscular system
performs during voluntary muscle activation. Although research has shown STA to
be a valid and reliable technique to estimate MU numbers [66, 67, 71, 73], there are
some inherent limitations to this approach. Due to increasing complexity of the
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EMG interference pattern with increased intensity of muscle contractions, STA is
limited to lower intensity contractions. It is well established, by Henneman’s size
principle [74], that smaller MUs are recruited first and larger MUs are recruited
later, when there is increased demand to overcome a load. Based on this principle,
STA may be artificially overestimating MUNEs by collecting a biased sample of
relatively small MUs that can be easily differentiated from a less complex
interference pattern at lower intensity contractions. Additionally, as STA requires
insertion of a needle electrode into the muscle, it is more invasive than some of the
other MUNE methods. Finally, it can be an extensively time consuming process, as
STA is only able to extract one MUP and S-MUP combination from each contraction,
and requires substantial cooperation from the participant to maintain a low
intensity muscle contraction.
1.0.10 Decomposition-enhanced spike-triggered averaging
In 1999, Stashuk [70] introduced a series of computer-based algorithms
capable of decomposing a complex intramuscular EMG interference pattern into
multiple discrete MUPs. Using the program decomposition-based quantitative EMG
(DQEMG) allowed multiple MUPs to be extracted from an interference pattern
during a single muscle contraction (Figure 1.2). The program was able to track
repetitive firings of multiple MUPs during the course of a 30 second contraction and
isolate characteristics of the MUP waveforms such as amplitude, duration, number
of turns, area etc. All of these characteristics were then averaged to create a MUP
template [70]. In 2004, Boe and colleagues [69] used these computer algorithms and
applied them to the conventional STA MUNE technique. This new technique, known
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as decomposition-enhance spike triggered averaging (DE-STA), was capable of
taking more complex, higher force needle EMG interference patterns and
decomposing them into their constituent MUPs. Therefore, by using this computer
based model, DE-STA is able to decrease the sampling bias of conventional STA by
allowed computer algorithms to decompose higher intensity contractions with more
complex interference patters, and reduced the time and patient cooperation needed
to calculate a MUNE.
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Figure 1.2. DQEMG
Example of a decomposition summary as depicted in DQEMG taken from a young
participant in this study. Each row represents one motor unit collected over the
span of a 30 second contraction. The first column depicts the motor unit potential
(MUP) template, which is the MUP waveform averaged across all firings of the MUP
(the number of MUP firings is represented in the bottom left corner of the MUP
template window). The second column is known as the shimmer plot, and shows all
of the MUP firings superimposed on top of each other. This gives an indication of the
stability of the MU (Section 1.0.11). Column three illustrates the surface-detected
MUP (S-MUP), which is a representation of the surface EMG signal that is timelocked to the discharge of the needle detected MUP and represents the size of the
MU. The fourth column is the inter-discharge interval (IDI) histogram. This
histogram depicts the interval between consecutive discharges of the MUP, and is
used during data analysis to ensure the interval is normally distributed with a
coefficient of variation (CoV) of less than 0.3. Finally, the fifth column contains the
firing rate graph. The vertical lines along the bottom represent the individual MN
firings, whereas the line across the top shows the instantaneous firing rate.
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1.0.11 Neuromuscular junction instability
Although the precise underlying mechanism has not been delineated, there is
evidence to suggest that aging leads to neuromuscular junction (NMJ) remodeling,
which can compromise neuromuscular transmission [26, 75, 76]. Changes in
neuromuscular transmission are thought to precede MU loss [77-80] and therefore
may represent a clinically relevant precursor to sarcopenia. The stability of NMJ
transmission can be determined electrophysiologically by measuring the variability
in shape of MUPs across successive discharges of an individual MU. There are two
main electrophysiological measures of MUP variability known as jitter and jiggle.
Jitter represents the variability in timing of individual muscle fiber contributions to
the MUP from one discharge to another [77]. Thus, if there is a disruption in NMJ
transmission, the fidelity of the muscle fiber’s contribution to the MUP will be
reduced, resulting in an increase in the jitter measurement. Jitter has been
extensively studied and shown to be a valid and reliable measure of NMJ stability
[77, 81, 82], but will not be the focus of this dissertation. Jiggle, on the other hand,
represents the variability in the overall shape of the MUP across repeated MU
firings. Contrary to jitter, jiggle has been relatively minimally studied in the
literature, although it has been shown to be increased in patients with ALS [77] and
myasthenia gravis (MG)[78].
More recently, jiggle has garnered increased interest by researchers in studies
of the aging neuromuscular system [79, 80]. Stashuk [83] described a novel
approach to determining jiggle known as near fiber (NF) jiggle. NF jiggle uses the
same general concept as traditional jiggle (measuring MUP shape deviation at
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consecutive discharges), but uses a high pass filter to enhance the contribution from
muscle fibers closest to the concentric needle electrode (within ~350 µm) (Figure
1.3). This allows for a more robust quantification of muscle fibers and MUs in close
proximity to the needle electrode and prevents contamination from activity of other
MUs farther away from the needle detection site. Using this technique, Allen et al.
[79] were able to establish that patients with diabetic polyneuropathy had
increased NF jiggle when compared to age-matched healthy controls. Additionally, a
recent investigation by Hourigan and colleagues [80] found that healthy older adults
had increased NF jiggle when compared to younger adults. These findings support
the assertion that NF jiggle has utility clinically to determine instability in NMJ
transmission. Importantly, it has been reported that NMJ transmission instability
precedes MU loss [77, 78], thus, NF jiggle may be a more sensitive clinical
measurement of impending MU loss and consequent sarcopenia.
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(A)

(B)

Figure 1.3 NF Jiggle
Example of NF jiggle as depicted in DQEMG. Each waveform in the MUP raster
represents a different firing of the MU over the course of a 30 second contraction,
and are used to create the MUP template. The shimmer plot on the right side shows
all the MUP waveforms superimposed on top of each other. NF jiggle is the
variability in MUP shape across consecutive discharges. (A) – MUP with a low NF
jiggle value (18.2%) representing less variability in MUP shape and a more stable
NMJ. (B) – MUP with a higher NF jiggle (64.1%) representing more variability in
MUP shape and a less stable NMJ. Both images were taken from participants in this
study
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1.0.12 Tibialis anterior and vastus medialis
It is important to consider the physiology and function of the muscle under
study when evaluating the health of the neuromuscular system with age. For the
current investigation, muscles of the lower extremity that contribute to gait and
overall functional mobility were of interest. Additionally, we aimed to include both
proximal and distal muscles in our analysis to help delineate any potential lengthdependent axonal changes in neuromuscular degeneration. Thus, the two muscles
chosen for examination in this study were the tibialis anterior (TA) and the vastus
medialis (VM).
The tibialis anterior is located below the knee and along with the extensor
digitorum longus and extensor hallucis longus it makes up the anterior
compartment of the lower leg [84]. Attached proximally to the lateral condyle of the
tibia and to the superior portion of the lateral tibia and interosseous membrane, the
TA runs parallel to the tibia and inserts distally into the medial cuneiform and base
of the 1st metatarsal. Innervated by the deep fibular nerve, the TA functions
primarily to dorsiflex the foot at the ankle, but it also contributes to inversion of the
foot [84]. The TA is an ideal model for studies of mobility and aging as it has a
principle role during the gait cycle to eccentrically control the descent of the foot at
heel strike, as well as concentrically to ensure adequate toe clearance during swing
phase [85, 86]. Additionally, there are numerous studies that have investigated
electrophysiological and neuromuscular measurements in the TA from which a
historical comparison can be made [2, 28, 56, 80, 87, 88].
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The VM is one of the four quadriceps muscles that make up the bulk of the
anterior thigh. Its proximal origin is along the intertrochantic line as well as the
medial portion of the linea aspera of the femur [84]. It inserts distally into the
common quadriceps tendon, which runs over the patella and inserts into the tibial
tuberosity via the patellar tendon. The VM, like the rest of the quadriceps muscles, is
innervated by the femoral nerve and functions as a unit to extend the leg at the knee
joint [84]. The VM is also particularly important for patellar tracking, helping the
patella to stay centered in the intercondylar groove of the femur. Although the VM
undoubtedly plays an important role in gait (to help accept weight during heel strike
and maintain stability during stance) [85, 86], it also serves as an ideal model for the
purpose of this study as a larger, more proximal muscle. Additionally, the VM is a
key contributor to large powerful movements such as climbing stairs or sit-to-stand,
making it a prime candidate to investigate potential loss of muscular power with
age.
1.1 Overview of thesis chapters
The objectives of this thesis were completed through a series of three studies
examining nerves, muscles, strength, power and functional performance in the
lower extremity of young, healthy old and mobility-impaired older adults. The aim
of these investigations was to determine the differences in neuromuscular function
between young, healthy older adults and those with mobility impairment. First,
electrophysiological evidence of neuromuscular remodeling with age was examined
using quantitative EMG analysis (Chapter 2). Next, the difference in contractile and
non-contractile tissues components was studied using MRI (Chapter 3). Finally, in
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Chapter 4 how changes in the neuromuscular system and composition of muscle
with age affect strength and the ability to produce power was explored, with specific
emphasis on the velocity of muscle contraction.
1.1.1 Chapter 2 study objectives
•

To use DE-STA to evaluate quantitative MU properties of the TA and VM
muscles in young, mobility-impaired and healthy older adults

•

To assess NF jiggle in the TA and VM of young, mobility-impaired and healthy
older adults

1.1.2 Chapter 3 study objectives
•

To compare the total contractile and non-contractile muscle tissue volume in
the lower extremity of young, healthy and mobility-impaired older adults

•

To use MTR to assess the TA muscle quality and quantity

1.1.3 Chapter 4 study objectives
•

To establish how strength and power influence functional performance in
older females

•

To examine the differences between specific strength and specific power in
the ankle dorsiflexors and knee extensors of healthy and mobility-impaired
older adults

•

To determine the extent of muscle contraction velocity loss in healthy and
mobility-impaired older adults
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Chapter 2
Electrophysiological evidence of motor unit remodeling with age: A
comparison of healthy and mobility-impaired older adults

2.0

Introduction
The association between advanced age and a loss of total muscle mass was

first described by Irwin Rosenberg [1]. This observation, which became known as
sarcopenia, has been adapted over the years to incorporate the inherent complexity
of the aging process and the definition now includes the loss of muscle strength and
even power [2, 3]. This loss of strength and power is critical from the perspective of
functional mobility. As a person’s mobility is reduced they become more isolated,
lose the ability to complete tasks independently and their quality of life decreases,
while their mortality rate rises [4]. Researchers have identified several factors that
likely contribute to the development of sarcopenia with age, which include poor
diet, inactivity, hormonal variations, and degeneration of the neuromuscular system
[5, 6]. While all of these factors likely contribute in isolation, as well as cumulatively,
to the development of sarcopenia with age, degeneration of the neuromuscular
system has been extensively studied [5-12], and is known to be a primary
contributor to the loss of muscle mass and strength with age. Thus, this chapter will
focus on electrophysiologically identified neuromuscular function and how it
contributes to reduced mobility with age.
The MU is the fundamental component of the peripheral nervous system and
there are numerous studies to support the fact that MUs are lost with advanced age
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[5, 7, 9, 11, 13-16]. Most researchers agree that MU loss is relatively modest during
the first 6 decades of life, but demonstrate a steep reduction thereafter [5, 7, 8, 17,
18]. Interestingly, despite evidence of significant MU loss and neuromuscular
remodeling in adults over the age of 65, strength can be well maintained until much
later in life (70+ years) [7]. It has been theorized that this is the result of collateral
reinnervation, whereby a surviving motor neuron will sprout a collateral axonal
branch to reinnervate muscle fibers that have been left behind by a dying or
dysfunctional motor neuron. This would explain the relative preservation of
strength, despite electrophysiological evidence of MU loss. With continued MU loss,
eventually the compensatory mechanism is overtaken resulting in the observed loss
of strength in very old adults. Therefore, isometric strength alone may be
insufficient to capture the progression of sarcopenia until a critical threshold is
achieved, wherein significant numbers of MUs have been lost and neuromuscular
remodeling can no longer keep pace with such losses.
Motor unit number estimation (MUNE) is an electrophysiological technique
developed to estimate the number of functioning MUs within a given muscle. MUNE
provides insight into the health and number of motor neurons supplying a muscle
and therefore may offer more information about the development and progression
of sarcopenia during the early stages of the degenerative process. Although many
different MUNE techniques have been developed and described in detail (for a
review see Gooch et al. [19]), decomposition enhanced spike-triggered averaging
(DE-STA) is one technique that has been shown to be valid and reliable in both
healthy participants and participants with neuromuscular disease [20-25].
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More recent research has focused on neuromuscular junction (NMJ)
transmission stability as a potential precursor to MU loss and subsequent
sarcopenia [14, 26-28]. Evidence suggests that the fidelity of NMJ transmission is
compromised with age [29-31]. Although the exact mechanism is yet to be
determined, this NMJ instability results in greater variability in the amplitude and
shape of motor unit potentials throughout the duration of a sustained muscle
contraction. This type of NMJ stability is known as “jiggle” and was first described by
Stalberg & Sonoo [26]. Stashuk [32] subsequently outlined a novel approach to this
measure, termed near fiber (NF) jiggle, which uses a high pass filter to amplify the
contributions of muscle fibers closest to the concentric needle electrode. In effect,
this allows for a more robust analysis of muscle fibers closest to the electrode, while
filtering out contamination from muscle fibers further away. NF jiggle has been
shown to be increased in people with diabetic polyneuropathy [28], as well as in
normal healthy older adults [14]
In recent years it has been suggested that sarcopenia can be categorized into
different stages of disease progression based on some key physical and
physiological measures. A European working group consensus outlined grip
strength, walking speed and muscle mass as three primary variables when defining
sarcopenia [33]. This is supported by previous literature, which identifies gait speed
as one of the most commonly reported alterations to mobility that occurs with aging
[34-36] with reduced mobility being linked to increased mortality rate [4]. A gait
speed of 1 m/s appears to represent a critical threshold for mobility, where people
below this threshold are at the highest risk for development of secondary
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complications related to their reduced mobility, and are defined as mobilityimpaired [33, 37, 38].
Thus, the purpose of this study was to use DE-STA to examine MU properties,
including NF jiggle, of the tibialis anterior (TA) and vastus medialis (VM) muscles in
a group of young, healthy old and mobility-impaired older adults. Our aim was to
categorize participants based on their mobility, rather than by age, to determine if
mobility-impaired older adults would exhibit greater indices of MU loss and
neuromuscular remodeling than similarly aged healthy adults. We hypothesized
that both groups of older adults would demonstrate electrophysiological evidence of
MU loss and neuromuscular remodeling, and further that these changes would be
even more apparent in mobility-impaired older adults.
2.1

Methods

2.1.1 Participants
A total of 30 individuals took part in this study. Participants were divided
into three groups: (1) healthy young adults (2) healthy older adults (3) mobilityimpaired older adults. To help maintain a more homogeneous sample, all study
participants were female. Female participants were selected because despite
representing a significantly larger proportion of the older population [39], they tend
to be less frequently studied. For inclusion in this study all participants were free
from any known neuromuscular or musculoskeletal disorders. Individuals with
diabetes were excluded from participation due to the well-documented impact of
diabetic polyneuropathy on the neuromuscular system. Healthy young adults were
recruited from the Western University graduate and undergraduate student
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population and though they were recreationally active, they were not involved in
any varsity or competitive sport/activity. Adults 65 years or older were eligible for
the healthy (gait speed greater than 1 m/s) or mobility-impaired (gait speed less
than 1 m/s) study groups. Healthy older adults were recruited from the Retirement
Researchers Association (RRA) run by the Canadian Center for Activity and Aging
(CCAA). The RRA is a group exercise program for adults 65 years or older. Mobilityimpaired older adults were recruited from an existing database of research
participants in the Gait and Brain Lab, led by Dr. Manual Montero-Odasso. Older
adults were excluded if they had a recent fracture affecting their mobility, implanted
metal device (such as hip or knee replacement), were unable to hold a moderate
intensity dorsiflexion or knee extension contraction, or were on blood thinners.
Older adults took part in a gait analysis screening session to categorize them into
the healthy or mobility-impaired study group.
2.1.2 Gait analysis
Participant’s walking was recorded and analyzed using the GAITRite system
(CIR System Inc., Franklin, NJ). Participants were positioned in front of a 10m mat
and asked to walk along the length of the mat. Participants set up ~2 feet from the
start of the mat to allow for acceleration so recording would begin at a steady state
gait, and were instructed to “walk right through” the far end of the mat to avoid
deceleration. They were specifically instructed to walk at their regular pace.
Following the first walk, they were asked to return to the starting position and
repeat the test two additional times (a total of three walks). The GAITRite system
provided real-time feedback to the experimenter on participant foot placement, step
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length, step width and gait speed. The data were stored on the GAITRite system and
later exported to Microsoft Excel for further analysis. The average gait velocity for
the participant across the three trials was recorded as that individual’s walking
speed, and was used to categorize older adults as healthy or mobility-impaired.
2.1.3 Grip Strength
Grip strength was assessed using a handheld hydraulic dynamometer
(JAMAR, Performance Health, Warrenville, IL). Participants were seated comfortably
holding the dynamometer in their dominant hand with their arm tucked in against
their side and elbow held at 90°. With verbal encouragement from the
experimenter, participants were asked to squeeze the handle as tightly as possible
for 3-4 seconds. The peak strength was recorded (in kilograms) and the
dynamometer was reset. This process was repeated two more times, with one
minute of timed rest between attempts, and the highest value achieved was
recorded as that participant’s grip strength.
2.1.4 Electromyography data collection
Electromyography (EMG) data were collected using the Viking EMG System
(Natus Medical Incorporated, San Carlos CA). Self-adhering Silver Mactrode®
electrodes (GE Medical Systems, Milwaukee, WI) were used to record surface
potentials, while intramuscular potentials were detected using 25 mm x 30 gauge
TECA™ elite Disposable Concentric Needle Electrodes (CareFusion, Middleton, WI).
A bandpass filter was used at 5Hz to 5kHz and 10Hz to 10kHz for surface and needle
recordings respectively.
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Informal screening asking “which hand do you write with” and “with which
foot would you feel most comfortable kicking a soccer ball” determined that all
participants were right hand/foot dominant, and thus all testing was performed on
the right limb. Participants were seated on a plinth with their back against a
backrest and both legs flat across the bed. Their skin was cleansed with 70%
isopropyl alcohol wipes in areas where surface electrodes would be affixed. For
testing on the TA, the active electrode was placed over the motor point of the muscle
(~7cm distal to the tibial tuberosity, 2cm lateral to the border of the tibia). The
experimenter confirmed and repositioned this electrode, if necessary, based on the
signal obtained from the excitation of the motor nerve (see below). The reference
electrode for the TA was placed over the distal tendon of the TA, which was
palpated by asking the participant to dorsiflex their foot against resistance provided
by the experimenter. Finally, the ground electrode was positioned over the patella.
Similarly for the VM, the active electrode was positioned over the muscle belly of the
VM, approximately 2cm superior to the vastus medialis oblique (VMO), whereas the
reference electrode was positioned over the patellar tendon and the ground
electrode once again on the patella. For both muscles, active and reference
electrodes were 1cm X 3.5cm and ground electrodes were 2.5cm X 3.5cm.
For the TA, a compound muscle action potential (CMAP) was determined by
delivering a series of 0.1 ms electrical impulses to the common fibular nerve. A
bipolar stimulator was positioned over the common fibular nerve, just posterior to
the head of the fibula, and the intensity of the stimulus was increased until the
amplitude of the CMAP plateaued. If necessary, the active electrode was then
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repositioned to decrease the rise time and maximize the negative peak amplitude of
the CMAP, ensuring the electrode was directly over the motor point of the muscle.
After a plateau was reached, the stimulus intensity was increased another 20% to
ensure activation of all motor axons. Once a suitable CMAP had been recorded and
saved, the experimenter then affixed all electrodes in position using surgical tape to
prevent displacement during further testing. A CMAP was not collected for the VM
due to limitations in the validity and reliability of maximally stimulating the much
larger femoral nerve, as well as EMG interference and contributions from large
nearby muscles innervated by the femoral nerve [9, 40]. Thus, a MUNE was not
calculated for the VM muscle in this study.
For the collection of intramuscular EMG recordings, the concentric needle
electrode was inserted into the muscle under study, either slightly proximal or distal
to the active surface electrode. The participant was then asked to contract against
resistance provided by the experimenter and aimed to maintain a contraction
intensity between 40-60 pulses per second (pps) for 30 seconds. The contraction
intensity in pps represents the aggregate average of motor unit potential (MUP)
discharge rate during one second of the EMG interference pattern. To help maintain
adequate contraction intensity, participants received verbal feedback from the
experimenter, visual feedback from a computer screen showing pps, as well as
auditory feedback from the EMG signal. After each contraction the experimenter
adjusted the location of the intramuscular electrode by either altering the depth of
the electrode insertion into the muscle, or changing the orientation of the electrode
tip. This allows for the collection of different MUs throughout the muscle. This
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process was repeated until a sample of at least 20 isolated MUPs and respective SMUPs was collected.
2.1.5 EMG signal decomposition and analysis
Once EMG signals were acquired using the Viking EMG System (Natus
Medical Incorporated, San Carlos CA), they were automatically exported into
DQEMG for further analysis. DQEMG uses a series of computer algorithms to
decompose and isolate individual MUPs from a complex EMG interference pattern.
For a detailed review of the process and algorithms used to decompose the EMG
pattern see [24, 41]. Briefly, the program is able to decompose the complex EMG
interference pattern into constituent MUPs and track their firing over the course of
the 30-second contraction to extract multiple MUP trains. The MUPs are used as a
trigger and time locked to the surface EMG signal. Thus, every time the computer
detects a MUP firing, the concomitant surface EMG signal is extracted and held for
processing. The S-MUP is then calculated based on the ensemble average of the
surface EMG signal associated which each individual firing of the MUP.
Using DQEMG, the same experimenter inspected all data to ensure they met
inclusion/exclusion criteria. First, a MUP train must have consisted of at least 51
MUP firings. Next, MU firing rates were examined to ensure they were within
physiological range. This was accomplished with the assistance of the interdischarge interval (IDI) histogram as well as the instantaneous firing rate plot. The
experimenter reviewed the IDI histogram to ensure it followed a normal
distribution and had a coefficient of variation (CoV) of less than 0.3. The
experimenter then inspected the instantaneously firing rate plot, which should
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create a reasonably straight horizontal line. If the IDI histogram displayed a nonnormal distribution (CoV > 0.3) or the instantaneous firing rate plot was not a flat
horizontal trace, the MUP was excluded from further analysis. A visual inspection of
the MUP waveform was then conducted to rule out cannula potentials. Cannula
potentials are inverted sharp positive waveforms that result from the recording of
of the MUP by the cannula of the needle electrode. Any cannula MUPs were excluded
from analysis; however, the S-MUP associated with the cannula potential was
retained as the cannula potential still served as an appropriate trigger for surface
EMG signal recordings. Finally, DQEMG would occasionally flag two MUP trains as
“disparate”, meaning those two MUP never fired at the same time during the 30
second contraction and it is possible that they originated from the same motor axon.
In this scenario the experimenter visually reviewed the two MUPs, if they were
deemed to look visually similar (similar shape, amplitude, number of turns etc.)
then the MUP with the fewest number of discharges was excluded. Otherwise, both
MUPs were included in the analysis.
Once all MUP and S-MUPs were deemed acceptable by the above criteria, the
experimenter then visually inspected each individual waveform and adjusted
markers (when applicable). MUPs had four markers (onset, negative peak, positive
peak, offset) and S-MUPs had three markers (negative onset, negative peak, positive
peak) (Figure 1). The same experimenter performed DQEMG analysis for all
participants in this study. While adjusting these markers, two finals checks to the SMUP were performed. First, the experimenter confirmed that the signal to noise
ratio of the S-MUP was greater than 10. Any S-MUPs with a signal to noise ratio of
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less than 10 were excluded from analysis. Second, the experimenter confirmed that
the S-MUP occurred within 10ms of its trigger MUP. Once analysis was complete,
DQEMG automatically calculated descriptive statistics based on all the included
MUPs and S-MUPs. A data point-by-data point average was used to create a template
S-MUP from which a MUNE could be calculated. For the purposes of this study the
negative peak amplitude was used to determine MUNEs, as it has been shown to be
a valid and reliable method for calculating MUNE [20-22]
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A

B

Figure 1. MUP and S-MUP
A – An example of a typical MUP as detected by the concentric needle electrode. The
MUP contains markers for (1) – onset (2) – positive peak (3) – negative peak (4) –
offset. B – An example of a typical S-MUP detected by the surface electrode and
represented in DQEMG. S-MUP markers denote (2) – negative onset (3) negative
peak (4) – positive peak. Markers are automatically set by DQEMG software. The
same experimenter visually inspected and adjusted marker location if applicable.
(Modified from: McKinnon, NB, Monterro-Odasso, M, Doherty, TJ. Motor unit loss is
accompanied by decreased peak muscle power in the lower limb of older adults.
Experimental Gerontology. 2015; 70: 111-8) [9]
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2.1.6 NF Jiggle
Neuromuscular stability was assessed by NF jiggle, which was calculated
using DQEMG software. This process has been described in detail previously [28]. In
short, using a second order low-pass differentiator, the MUP template was high-pass
filtered to create a NF MUP waveform. The NF MUP represents the contributions of
only those muscle fibers closest to the recording surface of the needle electrode
(~350 µm). A sample of 51 NF MUPs are then randomly selected and represented in
a raster plot on screen. The experimenter completed a visual inspection of the NF
MUPs to ensure they were appropriate for inclusion in the stability measurement.
NF MUPs were excluded and replaced if they were deemed to have signal
contamination from activity of nearby MUs. This process was repeated for every
MUP included in the study and DQEMG automatically calculated the overall NF jiggle
for each participant.
2.1.7 Statistics
All data is presented as mean ± standard deviation (SD). Statistics were
analyzed using Statistical Package for the Social Sciences (Version 21; IBM SPSS Inc.,
Chicago, IL). A Kruskal Wallis H test was used to identify any difference between
groups on MU properties. If a significant difference was detected, post-hoc analysis
consisted of individual Mann Whitney U tests between groups with a modified
Bonferroni correction to account for inflated alpha error. A significance level of
p≤0.05 was used for all statistical tests.
2.2

Results

2.2.1 Participants
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A total of twelve young adults (mean age: 25 ± 2 years), eleven healthy older
adults (mean age: 74 ± 6 years) and seven mobility-impaired old adults (mean age:
72 ± 5 years) were tested. There was no difference in height (chi-square= 3.38,
p=0.185) or weight (chi-square= 6.19, p=0.056) between the three experimental
groups, and no difference in age between healthy old (74 years) and mobilityimpaired older adults (72 years) (p=0.536). Both older adult groups had
significantly reduced grip strength (chi-square= 12.12, p= 0.002) when compared to
young adults (z= -3.15, p=0.01, z= -2.54, p=0.01 for healthy older and mobilityimpaired older adults respectively). Mobility-impaired older adults had an average
gait speed of 0.89 ± 0.10 m/s, which was significantly slower than the 1.24 ± 0.17
m/s gait speed of healthy old adults (z= -3.49, p<0.001). Participant information is
summarized in Table 1. Although gait speed was not calculated for young control
subjects in this study, normative data from previous research shows healthy young
adults to have a gait speed between 1.2-1.6 m/s [42, 43, 44, 45].
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Table 1. Study Participant Demographics

Sample size
Age (years)
Height (cm)
Weight (kg)
Gait speed (m/s)
Grip Strength (kg)

Young

Old

MI

12
25 (2)
165 (5)
63.4 (13)
32 (6)

11
74 (6)*
164 (5)
70.0 (9)
1.24 (0.17)
24 (4)*

7
72 (5)*
161 (4)
79.5 (21)
0.89 (0.10)*
23 (8)*

Values presented as mean (standard deviation). * indicates significantly different
from young. MI = mobility-impaired
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2.2.2 TA MU properties
An average of 24 ± 2, 25 ± 3, and 24 ± 3 MUPs were collected from the TA
muscle in young, old and mobility-impaired participants, respectively. From a mean
of 5 total contractions, 25 ± 2 valid S-MUPs were obtained in young subjects
resulting in an average of 5 ± 1 S-MUPs collected per contraction. For healthy old
adults, 25 ± 3 S-MUPs were collected from an average of 4 contractions resulting in
6 ± 1 S-MUPs/contraction. Mobility-impaired older adults had on average 5 ± 1
contractions to collect 24 ± 2 valid S-MUPs, or 5 ± 1 S-MUPs per contraction.
Contraction intensity, based on needled detected pps, did not differ between young,
old and mobility-impaired adults (chi-square=0.32, p=0.85), indicating that MU
properties were sampled at similar contraction intensity between experimental
groups. A significant difference in CMAP negative peak amplitude was detected
between experimental groups (chi-square=9.56, p=0.008). CMAP negative peak
amplitude was 7.9 ± 2.0 mV in young subjects, which was significantly larger than
the CMAP of 6.5 ± 0.9 mV in healthy old (z= -2.03, p= 0.04) and 5.2 ± 1.4 mV in
mobility-impaired older adults (z= -2.53, p= 0.01). Although S-MUP negative peak
amplitude did increase in both groups of older adults (30 ± 12 μV, 51 ± 44 μV, 42 ±
23 μV for young, old, and mobility-impaired respectively), this difference was not
statistically significant (chi-square= 1.76, p= 0.415). For MUNE, a significant
difference between groups was detected (chi-square= 6.33, p= 0.04). Post-hoc
analysis determined there was no statistical difference (z=-1.9, p=0.06) in MUNE in
the healthy older adults (MUNE: 193 ± 113) compared to young adults (MUNE: 287
± 110); however, MUNEs in mobility-impaired older adults (MUNE: 160 ± 87) was
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significantly reduced compared to young adults (z= -2.28, p= 0.02). A significant
difference was also detected for NMJ stability (chi-square= 6.23, p= 0.04). Healthy
older adults had significantly greater NF jiggle (31.8 ± 6.5%) when compared to
young subjects (25.3 ± 3.7%) (z= -2.59, p= 0.009). Interestingly, although mobilityimpaired older adults also had a larger NF jiggle value (30.3 ± 8.4%), it was not
significantly larger than the young controls (z= -1.35, p= 0.196) (Table 2).
2.2.3 VM MU properties
For the VM muscle, a total of 24 ± 3, 24 ± 2, and 27 ± 2 MUPs were sampled
for young, old and mobility-impaired respectively. For young participants, an
average of 5 total contractions were used to obtain 26 ± 3 valid S-MUPs, or 5 ± 1 SMUP’s collected per contraction. Older adults required 5 contractions to collect 24 ±
2 S-MUPs resulting in 5 ± 1 S-MUPs/contraction. 26 ± 2 valid S-MUPs were obtained
from 4 ± 1 contractions in mobility-impaired old adults, resulting in 6 ± 1 S-MUPs
per contraction. There was no difference between groups in needle-detected
contraction intensity during the acquisition of MUP data (chi-square= 0.81, p= 0.67).
In the VM, the S-MUP negative peak amplitude decreased from young (54 ±23 μV) to
old (45 ± 24 μV) to mobility-impaired older adults (29 ± 13 μV), although this
difference was not statistically significant (chi-square= 5.71, p=0.06). Additionally,
there was no difference (chi-square= 5.14, p=0.08) in NF jiggle values between
groups (18.6 ± 3.8%, 21.4 ± 4.3%, 22.1 ± 4.6% for young, old and mobility-impaired
old respectively) (Table 2).
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Table 2. Motor unit properties of young, old and mobility-impaired older adults in the tibialis anterior and vastus
medialis
Tibialis Anterior

Vastus Medialis

Young

Old

MI

Young

Old

MI

CMAP Neg Peak Amp (mV)

7.9 (2.0)

6.5 (0.9)*

5.2 (1.4)*

-

-

-

S-MUP Neg Peak Amp (μV)

30 (12)

51 (44)

42 (23)

54 (23)

45 (24)

29 (13)

MUNE (#)

287 (110)

193 (113)

160 (87)*

-

-

-

NF Jiggle (%)

25.2 (3.7)

31.6 (6.5)*

30.3 (8.4)

18.6 (3.8)

21.4 (4.3)

22.1 (4.6)

53 (5)

55 (12)

51 (10)

51 (9)

47 (9)

51 (7)

Intensity (pps)

Both groups of older adults had significantly reduced CMAP amplitude in the TA muscle compared to young adults (p= 0.04, p=
0.01 for healthy and mobility-impaired old respectively). MUNEs were significantly reduced in mobility-impaired older adults
(p= 0.02), but not healthy older adults (p=0.06). Only healthy older adults had significantly larger NF jiggle compared to young
(p= 0.009). For the VM, S-MUP amplitude decreased from young to healthy old to mobility-impaired older adults, although this
difference was not statistically significant (p= 0.06). There was no difference in NF jiggle between groups in the VM muscle (p=
0.08). There was no difference in contraction intensity during EMG recording between groups in either muscle tested (p= 0.85,
p= 0.67 for TA and VM respectively). Values are presented as mean (standard deviation). * Indicates a significant difference
from young. MI: mobility-impaired
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2.3 Discussion
This study was designed to determine if older females with mobility
impairment, defined by a gait speed of less than 1 m/s, would demonstrate
electrophysiological evidence of greater MU loss and neuromuscular remodeling
when compared to healthy age-matched and young controls. We observed
indications of MU loss in in the TA of both groups of older adults, which appear to be
more substantial based on the calculated MUNE in the mobility-impaired
population. Our findings are in line with previous research indicating sarcopenia is
not a function of aging alone, but rather a result of a complex interaction of multiple
variables affecting a person’s muscle mass, strength and overall mobility [8, 12, 46].
Thus, classification of persons with sarcopenia should not be defined based on age;
instead, sarcopenia should be categorized based on a combination of defined
normative values for muscle mass, strength and function [33].
Due to its functional significance during locomotion and the ease of access to
the superficial muscle belly and peripheral nerve supply, the TA muscle is an ideal
model for studies of neuromuscular function with age. Several studies have
previously examined MU properties of the TA muscle in populations of healthy
young adults, older adults and individuals with neuromuscular disorders [7, 9, 18,
47-49]. A previous study from our lab [9] investigated the relationship between
MUNEs and muscular power in the TA and VM muscles of young and older adults. It
was observed that older participants had significantly reduced MUNEs in the TA
compared to young adults, and that this appeared to be the result of significantly
larger S-MUPs in the older adults. This observation is in line with the pattern of
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neuromuscular remodeling with age; as MUs are lost, through the process of
collateral reinnervation, the average size of individual MUs (i.e. S-MUP) increases.
The values reported for MUNE (young: 233 ± 109; old: 102 ± 76) and S-MUP
negative peak amplitude (young: 27 ± 14 μV; old 63 ± 29μV) in that paper are in
accordance with the values reported in the current study.
Several other studies have examined MUNEs in the TA muscle. McNeil and
colleagues [7] compared MUNE and strength in young, old (65-79 years) and very
old (80+ years) adults. They reported a decrease in MUNE between groups (young:
150; old: 91; very old: 59), but intriguingly strength was maintained compared to
young in the old group, but reduced compared to young in the very old. The authors
suggested that through collateral reinnervation, isometric strength is maintained
until a critical threshold of MU loss is reached. More recent research however
suggests that power may be more sensitive to MU loss associated with sarcopenia
[9, 12]. As the larger fast twitch muscle fibers are lost at a greater proportion than
the smaller, habitually active slow twitch fibers, there is a systemic slowing of
muscle contraction velocity. Thus, even though some of the lost muscle fibers are
reinnervated resulting in the maintenance of isometric strength during the early
stages of dennervation, whole muscle contraction velocity is reduced, which
manifests in a deficit in muscle power.
Another study by Power et al. [18] examined the effects of high-level lifelong
physical activity on MU loss in the TA by comparing normal healthy older adults
with “master runners” who regularly trained and competed in long distance races
throughout their life. They found MU loss was attenuated in the master runners,
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concluding that MU loss with age may be activity dependent. While the study by
Power et al. [18] was able to establish that life-long physically active individuals
may attenuate the development of sarcopenia, the current study observed the
opposite end of the spectrum. Investigating older adults without any underlying
neuromuscular or musculoskeletal disorders, we were able to demonstrate that
those with reduced mobility showed greater indications of sarcopenia based on
their estimated number of functioning MUs.
Interestingly, for the present study, although S-MUP negative peak amplitude
in the TA was not significantly larger compared to young participants, MUNE was
significantly reduced in the mobility-impaired older adults. Also of note, the S-MUP
amplitude increased from 30 μV to 51 μV from young to healthy old adults, but then
decreased slightly to 42 μV in mobility-impaired adults. Although this may seem
contrary to the established model of neuromuscular remodeling with advancing age
whereby MU loss leads to the expansion of surviving motor neurons [7], it may be
explained as an accelerated progression of sarcopenia in the mobility-impaired
older adults. It is feasible that the mobility-impaired older adults, who have
presumably experienced greater MU loss (based on derived MUNE values), may
have outpaced the compensatory reinnervation process. Thus, the observed
decrease in S-MUP amplitude in these participants may be the result of continued
MU loss, as some of the larger reinnervated parent motor neurons are lost. This
notion is supported by significantly lower CMAP observed in mobility-impaired
older adults, indicating that the overall MU pool has been reduced.
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In comparing MUNEs in the current study with those of previously published
values for the TA [7, 18, 48, 49], it is apparent that our results are slightly higher
across all 3 groups. It is important to distinguish that most of these previous studies
had a sample consisting of all (or mostly) male participants, whereas the present
study contained all female participants. It is well documented in the literature that
estrogen has neuroprotective effects [59, 60]. A study by Nakamizo et al.
demonstrated that 17α-estradiol prevented nitric oxide induced motor neuron
death in the spinal cord of rats [61]. Additionally, estrogen has been found to reduce
oxygen free radicals, providing an antioxidant effect [59, 60]. Granted the older
females in this study would be post-menopausal and have significantly reduced
circulating estrogen levels; however, it is possible that the exposure to the
neuroprotective effects of estrogen throughout the course of their adult life may
have attenuated the progression of inflammation and oxidative stress normally
experienced by motor neurons [62, 63]. Relatively few studies have examined
differences in sex on MUNE, and those that have found that there was no difference
in MUNE between males and females using traditional STA [11] and multiple point
stimulation [64, 65]. Interestingly, all of these studies assessed muscles of the upper
extremity (biceps brachii, brachialis, abductor pollicis brevis, abductor digiti
minimi), to our knowledge no study to date has investigated sex differences in
MUNE in the lower extremity muscles, or using DE-STA. Considering the importance
of lower extremity muscles to mobility and function with age, and given that females
tend to live longer and represent a significantly larger proportion of the older adult
population than males [39], this may be an important area for future research.

50

The VM, on the other hand, has had comparatively fewer studies conducted
of MUNE. Berger and colleagues [50] used DE-STA to investigate MU properties in
the VM of healthy older adults (62 ± 6 years) and reported an average S-MUP
negative peak amplitude of 41 ± 29 μV, which is similar to the values reported here.
As well, a study by Conwit et al. [20] investigated the effects of contraction level on
S-MUP negative peak amplitude in the VM using DE-STA in a sample of adults with
an age ranging from 21-70 years. At contraction levels of 20% and 30% MVC (which
most closely resemble the intensity of muscle contraction used in the current study)
the authors reported S-MUP amplitudes of 41.3 μV and 53.5 μV respectively. These
values are remarkably similar to those presented in the current study for young (54
μV) and healthy old adults (45 μV).
Results from a previously published study out of our lab show an increase in
S-MUP amplitude from 48 μV in young to 60 μV in older adults [9]. In the current
study however, we observed a decrease in S-MUP amplitude from young (54 μV) to
healthy old (45 μV) to mobility-impaired old (29 μV). Hourigan and colleagues [14]
observed a similar trend in a previous study of neuromuscular function in the VM.
The authors recorded S-MUP negative peak amplitudes of 76 μV in young and 66 μV
in healthy older males. Additionally, a recent study investigating age-related
neuromuscular changes in the vastus lateralis found a similar decrease in S-MUP
negative peak amplitude from young (96.7 μV) to older adults (87 μV) [40]. It has
been suggested that due to the larger more disperse MU territories and increased
depth and distance of contributing muscle fibers to the surface electrode, that larger
more proximal muscle, such as the VM, may not provide an accurate reflection of the

51

actual MU size in these muscle [9, 51]. Previous studies have estimated the
recording radius of a surface electrode to be less than 20 mm [52], which in a large
muscle such as the VM, is unlikely to pick up the contributions from all of the muscle
fibers of a MU. Additionally, it has been shown that older adults have increased
subcutaneous and intramuscular adipose tissue [5, 53, 54], and that these tissues
overlying muscle can attenuate EMG signals [55]. Data presented in Chapter 3 show
that both groups of older females in this study have significantly greater
subcutaneous adipose tissue compared to healthy young adults. Therefore, it is
reasonable to speculate that the decrease in S-MUP amplitude observed in the VM
muscle of the current study may be related to the attenuation of EMG signal activity
rather than a presumed decrease in MU size. As large proximal lower extremity
muscles are critically important for gait and mobility, it is important for future
research to investigate different ways to accurately record and track neuromuscular
changes in these muscles.
NF jiggle represents the variability in the shape of the MUP across successive
discharges. It has been suggested that sarcopenia compromises the fidelity of the
NMJ leading to increased variability in neuromuscular transmission [29], and that
this may occur prior to actual MU loss [26, 27]. In the present study, NF jiggle in the
TA increased from 25.2% in young participants to 31.6% and 30.3 % in healthy
older adults and mobility-impaired older adults respectively. These values are
similar to previous studies investigating NF jiggle of the TA in older adults [14, 28].
Interestingly, NF jiggle was significantly increased in healthy older adults, while
MUNEs were unchanged, providing further support that NMJ instability may be a

52

clinically useful measure of neuromuscular damage and impending MU loss [14, 26,
28, 56].
NF jiggle values obtained for the VM in the present study were not
significantly different between study groups. This is in contrast to a previous study
investigating NF jiggle in young and healthy older males [14]. Using the same
technique used here, Hourigan et al. [14] reported an increase in NF jiggle values in
the VM from 23.9 ± 4.2% in the young to 31.3 ± 5.5% in older adults. There is some
evidence in the literature to suggest that more proximal muscles may be relatively
preserved from the effects of age-related neuromuscular degeneration compared to
distal muscles [9, 57, 58]. However, the conflicting results between these two
studies highlight the necessity for further research into sarcopenia and
neuromuscular changes in large proximal muscle groups.
A recent investigation by Gilmore and colleagues [56] compared MUNEs and
NF jiggle of the TA muscle in older adults categorized based on 3 levels of
sarcopenia (pre-sarcopenic, sarcopenic, and severely sarcopenic). The authors
reported no difference in CMAP, S-MUP amplitude or MUNE between the three
groups. However, they did find that NF jiggle was significantly greater in the
severely sarcopenic group compared to both the pre-sarcopenic and sarcopenic
groups (31% and 26% greater respectively). Contrary to Gilmore et al. [56], the
present study demonstrated a significant decrease in CMAP in both groups of older
adults, and a significant decrease in MUNE in mobility-impaired adults. The current
study also shows a 25% and 20% increase in NF jiggle compared to young for old
and mobility-impaired adults respectively. In the study by Gilmore et al. [56]
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participants were categorized based on three key variables associated with the
progression of sarcopenia (grip strength, muscle mass and gait speed). Although age
was not considered in their classification, there was a tendency towards adults with
greater degrees of sarcopenia being older (mean age pre-sarcopenic: 75 years;
sarcopenic: 78 years, severely sarcopenic: 82 years). In contrast, the present study
categorized participants based on gait speed and controlled for mean age between
healthy and mobility-impaired groups. It should be noted that the mean age in the
present study is on the lower end of the range of participants in the study by
Gilmore et al. [56]. Nonetheless, both studies underscore the importance of
categorizing sarcopenia based on physical and functional performance rather than
age.

The present study is not without limitations. First, the sample size, especially

in the mobility-impaired population, is relatively small, which limits the power of
our analysis and therefore our results are conservative estimates of effect. However,
it should be noted that previous studies of MU properties and EMG measures have
reported significant results with similar sample sizes [7, 14, 18, 56]. Additionally, for
the VM we did not record a CMAP from which we would have been able to
normalize obtained S-MUP values to. This decision was made intentionally, as the
reliability and validity of CMAP’s obtained from this muscle have previously been
called into question due to difficulty maximally stimulating the femoral nerve and
because of EMG interference from large muscles nearby that are also activated with
stimulation of the femoral nerve [9, 40]. Finally, the cross-sectional design of this
study limits the generalizability and conclusions that can be drawn from this study.

54

As only females were studied this does not necessarily represent all people within
these age groups, therefore we cannot generalize these results to all older adults.
In summary, the purpose of this investigation was to determine if motor unit
loss and neuromuscular remodeling was accelerated in older adults with mobility
impairment compared to healthy age-matched and young controls. In accordance
with recently published work [33, 56], the current study provides
electrophysiological evidence that sarcopenia is not defined by age alone, but rather
the combination of multiple factors that contribute to the loss of strength, muscle
mass and mobility as we age. Future research into sarcopenia and aging should
focus on categorizing participants based on their level of impairment rather than
their age, with emphasis on proximal muscles of the lower extremity, which are
critically important to mobility. As well, further longitudinal studies into EMG
evidence of neuromuscular remodeling at different stages of sarcopenia with aging
are needed.
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Chapter 3
Investigating contractile and non-contractile muscle tissue
components in healthy and mobility-impaired older adults

3.0 Introduction
Sarcopenia is the term used to describe the natural aging process whereby
muscle mass and, subsequently, strength are lost [1, 2]. The progression of
sarcopenia contributes to impaired mobility, and has been linked to increased
disability in older adults [3]. The degradation of contractile muscle mass is the
hallmark symptom of sarcopenia, and it is therefore important for studies of
sarcopenia and aging to accurately document and record the atrophy of muscle
tissue in vivo. Early studies used limb circumference measurement in an attempt to
track muscle atrophy with advanced age; however, availability of new technologies
has demonstrated the inadequacy of these measurements to accurately reflect
changes in contractile muscle tissue [2-7].
First, although skin fold caliper testing can help to partially control for
increases in subcutaneous adipose tissue (SAT), it is difficult to precisely control
when measuring circumferential limb girth. Additionally, results from muscle
biopsies [8] as well as imaging studies [3-6] consistently demonstrate that older
adults have a larger proportion of intramuscular adipose tissue (IMAT) when
compared to healthy young adults. Evidence suggests the accumulation of fat within
muscle has a negative impact on mobility and lower extremity functional
performance [9]; thus, a valid and reliable method to quantify the amount of muscle
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mass separated from adipose tissue is required for the accurate tracking of
sarcopenia in older adults.
Many techniques have been used to determine the size of limb muscles
including ultrasound, dual-energy X-ray absorptiometry (DEXA), computed
tomography (CT) and magnetic resonance imaging (MRI) [2, 4-6, 10, 11]. Due to its
ease of use, high quality images and lack of exposure to radiation (such as that
required for CT scanning), MRI has become one of the most predominantly used and
gold standard methods for calculating muscle mass. Additionally, MRI has shown to
be valid and reliable in the quantification of muscle tissue components [12, 13],
whereas DEXA has been reported to potentially underestimate the loss of muscle
mass associated with aging [10].
MRI is a non-invasive technique that uses extremely strong magnetic fields to
image soft tissue structures. Using the principles of magnetic resonance,
technologists can take advantage of the inherent differences in how fluids and fats
behave when exposed to these strong magnetic fields. This allows for the production
of high quality images of soft tissue in vivo. Due to advancements in technology, MRI
has become faster and more practical for use in research. Furthermore, due to
improvement in image quality, MRI is also able to segregate IMAT and other noncontractile tissue from within the muscle itself, allowing for the calculation of total
contractile muscle mass. As it has been well established that MU loss leads to muscle
fiber atrophy, which is supplanted by fat and connective tissues [2, 14],
quantification of IMAT and total contractile muscle mass are important markers of
sarcopenia in older adults.
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Recently, researchers have described a novel MRI technique known as
magnetization transfer (MT) (for a review see Henkelman et al. [15]). Although this
technique was first used in studies of multiple sclerosis to record lesions in white
matter of the brain [16, 17], it has increasingly been adapted for use in many other
areas, including in skeletal muscle to assess muscle protein quality and quantity. MT
uses an off-resonance radio frequency (RF) pulse to saturate water-bound proteins
within the muscle, causing images with higher protein content to appear darker. A
magnetization transfer ratio (MTR) can then be calculated by comparing images
with the off-resonance RF pulse to those without [18, 19]. The ratio of change
between these two images represents the quality of protein within the selected
muscle. Previous studies have used MT to assess muscle protein quantity in the TA
muscle and have reported reduced MTR in old adults [20], very old adults [21] and
in individuals with diabetic polyneuropathy [22].
Thus, the purpose of this study was to use MRI to determine the total
contractile muscle mass and amount of non-contractile tissue in the ankle
dorsiflexors and knee extensor muscles in young, healthy old, and mobility-impaired
older adults. Additionally, we aimed to investigate muscle protein quality and
quantity in these muscle groups using this novel MT approach. Previous research
has reported that older adults have increased IMAT in the ankle dorsiflexors [3, 20,
21] and knee extensor muscles [6, 7], and that increased IMAT has been linked to
decreased mobility and poor functional performance in lower extremity muscles [9].
However, to our knowledge, no study to date has investigated these measures in a
group of mobility-impaired older adults. Therefore, we hypothesized that both
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groups of older adults would demonstrate reduced muscle mass and increased
IMAT, with mobility-impaired older adults expressing even greater deficits than
healthy old adults.
3.1 Methods
3.1.1 Participants
Participants were divided into one of three experimental groups based on
their age and mobility status. Young participants were between the ages of 22-28
years old and recruited from the Western University student population. For
inclusion to the older adult population participants must have been over the age of
65 years and have no signs of underlying health conditions which may affect muscle
or nerve health. All older adults took part in a walking test to determine gait speed.
Participants with a gait speed of greater than 1 m/s were classified as healthy older
adults, and those with a gait speed of less than 1 m/s were classified as mobilityimpaired. A gait speed of less than 1 m/s has previously been described as a critical
threshold for mobility impairment in older adults [23-25]. All participants in this
study were female.
3.1.2 Magnetic resonance imaging
MRIs were acquired using a Dixon technique with fat suppression via a 3T
magnet (Magnetom Verio, Siemens Healthcare, Erlangen, Germany). Participants
were positioned supine on the MRI table and straps were positioned around their
feet and legs to prevent excessive movement during imaging. For the TA, a RF coil
was positioned over the area being imaged (from the tibial plateau to the malleoli)
and the participant was inserted into the bore of the magnet feet first. Sixty-six
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images were acquired with a slice thickness of 5mm and no slice separation. A
repetition time (TR) of 3000ms, echo time (TE) of 11ms and flip angle of 180° was
used.
Due to the increased length of muscle mass being imaged for the anterior
thigh muscles, two RF coils were used for these images. Each RF coil collected 58
images with a thickness of 5mm and no separation with parameters the same as
outlined above. This provided some overlap of images, which were excluded during
analysis.
3.1.3 Determination of muscle CSA, volume, and contractile/non-contractile
tissue
All MRIs were analyzed using OsiriX DICOM viewer (Version 11.0.2, Prixmeo
SARL, Geneva, Switzerland). Images were analyzed using a semi-automated process
whereby the experimenter manually outlined a region of interest (ROI) on every
third image starting distally and working proximally until reaching the last slice
containing identifiable muscle tissue. For the ankle dorsiflexors, analysis began on
the first image proximal to the malleoli containing identifiable muscle tissue and
continued proximally to the tibial tuberosity. Similarly for the knee extensors, ROIs
began distally with the first identified muscle fibers of the VM and continued
proximally until the last slice containing muscle fibers of the rectus femoris. Due to
the use of two RF coils in the knee extensors, there was some overlap of images in
the middle of the thigh. For these images the experimenter visualized the area of
overlap side-by-side in the DICOM viewer and outlined the images with better
contrast while excluding the other images from analysis. The software was then
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used to interpolate missing ROIs based on the manually outlined areas. Next, the
experimenter visually inspected the computer-generated ROIs to ensure their
accuracy and manual corrections were made to the outlined area if necessary. Once
satisfied with the outlined muscle tissue, all pixels outside the ROI were set to zero
and the experimenter used the computer software to render a 3-dimensional (3D)
model of the muscle. Since there was no separation between slices in the image
capture process, this 3D model of the muscle represented the entire volume of the
muscle under study. The volume of muscle tissue was then determined
automatically by the software and recorded as the participant’s “total” muscle
volume. The experimenter then used the brush tool to manually subtract any nonmuscle tissue from the images (i.e., fat, connective tissue, septal space,
neurovascular tissue etc.)(Figure 1). The same experimenter analyzed all images for
all participants in the study. The muscle volume was then computed again and
recorded as the participant’s “contractile” volume allowing for the quantification of
fat, connective tissue and other non-contractile tissue in the muscle. The single
image slice with the largest area was recorded as the participant’s CSA for each
muscle group tested. The “contractile” CSA was subtracted from the “total” area to
determine non-contractile CSA. Previous research has used a similar technique for
MRI analysis of muscle composition [21, 26] and it has been shown to have a high
degree of inter- and intra-rater reliability [26].
The amount of SAT was also determined in the thigh. SAT was measured
from the single image with the largest total thigh muscle area, which was
determined by manually outlining a ROI that included the entire thigh musculature.
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Once the largest cross-section of muscle in the thigh was determined, the
experimenter then outlined the entire mass of the thigh using a second ROI. Within
this new ROI, the experimenter was then able to set a pixel value equal to an area in
the image containing only adipose tissue and render a 2D model using the computer
software. Finally, the experimenter used the brush tool to manually remove any
IMAT that was included in the 2D modeling. The remaining area consisted of only
the SAT and was recorded.
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B

C

D

Figure 1. MRI analysis and determination of muscle CSA and volume
Representative images of the process used to determine muscle CSA and volume in the anterior compartment. A – ROIs were
manually outlined on every third image starting distally. OsiriX software was then used to interpolate missing ROIs, which
were manually inspected and adjusted if necessary. B – Once a ROI was determined for each image, pixel values outside the
ROI were set to zero and a 3D region was determined by OsiriX software. The single image with the largest area was recorded
as the participants CSA. C – Using the brush tool function, an experimenter manually subtracted any non-muscle tissue or
septal spaces within the muscle from each MRI scan. The same experimenter examined all MRIs in the study. D – OsiriX
software could then render a 3D model of the entire muscle to determine muscle volume.
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3.1.4 Magnetization transfer
Muscle protein quality was assessed using the unique MRI protocol known as
MT. MT uses an off-resonance RF pulse to saturate protons in large macromolecules
(such as protein) to create additional contrast on images. These images can then be
subtracted by images without the off-resonance pre-saturation pulse to determine a
MTR and give an indication of the quality and quantity of protein in the muscle. A
total of 32 images were taken centered around the muscle belly, with a thickness of
5mm and no separation between slices. A TR of 1120ms, TE 5ms, and flip angle of
15° was used. The MT pulse used was similar to that described previously [27]:
gaussian, 10.2 ms long, 500° flip angle and 1200 Hz offset. Similar MT pulse
parameters have been used previously to assess skeletal muscle quality [21, 22].
Images with off-resonance pre-saturation were acquired first and images without
were obtained from the same anatomical location immediately following the first
scan.
A MTR was calculated from the image with the largest CSA, which was
determined in the ankle dorsiflexors by manually outlining the muscle to determine
the slice with the largest area. The examiner then selected an area of muscle tissue
without significant contamination of fat, connective tissue or other non-contractile
tissues and recorded the mean pixel value from this area as M1. The selected area
was then copied and pasted into the same location of the images without presaturation and the pixel value was recorded as M0. A MTR was then calculated using
the equation MTR = [M0-M1]/M0 (Equation 1). MTR is expressed as a ratio of relative
change from baseline (i.e. images without pre-saturation).
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3.1.5 Statistics
All statistical testing was completed using Statistical Package for the Social
Sciences (Version 21; IBM SPSS Inc., Chicago, IL). A Kruskal-Wallis H test was used
to identify any statistically significant differences between experimental groups. If a
statistical difference was detected, post-hoc analysis consisted of individual MannWhitney U tests between groups, with a modified Bonferroni correction. A
significance level of p≤0.05 was used for all statistical tests. Values are presented as
means ± standard deviation.
3.2 Results
3.2.1 Participants
Twelve healthy young participants (mean age: 25 ± 2 years), ten healthy older
adults (mean age: 74 ± 6 years) and six mobility-impaired older adults (mean age:
72 ± 6 years) took part in this study (Table 1). There was no difference in height
(chi-square= 3.38, p=0.185) or weight (chi-square= 6.19, p=0.056) between groups.
Gait speed was significantly reduced in mobility-impaired older adults compared to
healthy older adults (z = -3.49, p<0.001). Participant information is summarized in
Table 1.
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Table 1. Study Participant Information

Sample size
Age (years)
Height (cm)
Weight (kg)
Gait speed (m/s)

Young

Old

MI

12
25 (2)
165 (5)
63.4 (13)
-

10
74 (6)*
165 (5)
71.5 (8)
1.26 (0.17)

6
72 (5)*
161 (5)
79.8 (23)
0.87 (0.10)*

There was no difference between height (p= 0.185) or weight (p= 0.056) between
participants. Mobility-impaired adults had significantly slower gait speed than
healthy older adults (p<0.001). Values presented as mean (standard deviation). *
indicates a statistically significant difference. MI = mobility-impaired
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3.2.2 Ankle dorsiflexor muscle composition, CSA and volume
There was no difference in the total (chi-square= 1.7, p= 0.43) or contractile
CSA (chi-square= 2.56, p= 0.28) of the muscles in the anterior compartment
between young, old and mobility-impaired older adults. There was however a
significantly larger amount of non-contractile tissue in both groups of older adults
compared to young adults (chi-square= 9.35, p= 0.009). Older adults had 55% more
non-contractile tissue (z= -2.64, p= 0.007), while mobility-impaired older adults had
58% more non-contractile tissue (z= -2.42, p= 0.01) in their dorsiflexor muscle
groups compared to young adults. Similarly, there was no difference in total muscle
volume between the three groups in the ankle dorsiflexors (chi-square=4.22, p=
0.12). There was a significant difference between groups in total contractile muscle
volume (chi-square=8.43, p= 0.02). Post-hoc testing determined there was no
difference in contractile muscle tissue between young and healthy old adults (z=1.88, p= 0.06), while mobility-impaired older adults (162.2 ± 28.3 cm3) had
significantly reduced contractile muscle tissue volume compared to young
participants (206.6 ± 35.9cm3) (z= -2.62, p= 0.007). As well, both groups of older
adults had a greater volume of non-contractile muscle tissue compared to young
adults (chi-square=12.9, p= 0.002, z= -3.43, p<0.001, z= -2.34, p= 0.02 for healthy
and mobility-impaired adults respectively) (Figure 2), but were not different to one
another (z= -0.16, p= 0.86). When non-contractile tissue within the muscle was
expressed as a percentage of total muscle volume a significant difference was
detected between groups (chi-square= 18.25, p<0.001). Further analysis
determined healthy old adults (10.1 ±1.6%, z= -3.89, p<0.001) and mobility-
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impaired older adults (10.1 ±2.5%, z= -3.09, p=0.001) had twice as much noncontractile tissue volume as young adults (5%). Results for CSA and volume of the
ankle dorsiflexor muscles are summarized in Table 2.
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A

B

C

Figure 2. Representative sample of magnetic resonance images (MRI) of the ankle dorsiflexor muscles. A – young (25 years
old), B – healthy old (72 years old, walking speed: 1.5 m/s), C – mobility-impaired (72 years old, walking speed: 0.96 m/s)
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Table 2. Muscle CSA and Volume in the ankle dorsiflexors

CSA (cm2)
Total
Contractile
Non-contractile
Volume (cm3)
Total
Contractile
Non-contractile
% Non-contractile volume

Young

Old

MI

11.0 (2.1)
10.8 (2.0)
0.2 (0.2)

10.56 (1.1)
10.12 (1.3)
0.44(0.23)*

9.5 (2.1)
9.03 (2.1)
0.47 (0.19)*

217.7 (38)
206.6 (35.9)
11.1 (4.1)
5.0 (1.4)

201.8 (24)
181.6 (22.4)
20.2 (3.3)*
10.1 (1.6)*

180.7 (33)
162.2 (28.2)*
18.5 (6.0)*
10.1 (2.5)*

Both groups of older adults had approximately twice as much non-contractile CSA as
young adults (p=0.007, p=0.01 for healthy and mobility-impaired old respectively).
Mobility-impaired older adults had significantly less contractile muscle volume
compared to young adults (p= 0.007). Both healthy (p<0.001) and mobilityimpaired older adults (p=0.02) had significantly more non-contractile muscle
volume, and a two-fold increase in % non-contractile volume compared to young
adults (p<0.001, p=0.001 respectively). * indicates significantly different from
young. Values presented as means (standard deviation).
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3.2.3 Knee extensor muscle composition, CSA and volume
A statistically significant difference was detected between groups in total
(chi-square= 13.94, p= 0.001) and contractile (chi-square= 14.27, p=0.001) CSA.
Post-hoc tests confirmed significant reductions in the old (z= -3.17,p= 0.001 z= 3.23, p= 0.001 for total and contractile area respectively) and mobility-impaired
older adults (z= -3.0, p= 0.001 z= -3.0, p= 0.001 for total and contractile area
respectively) compared to the young adults (Figure 3). There was no difference,
however, in the amount of non-contractile CSA between young (2.1 ± 0.7 cm2), old
(2.5 ± 0.7 cm2), and mobility-impaired older adults (2.6 ± 0.7 cm2) (chi-square=
3.09, p= 0.21). A significant difference was detected for total knee extensor muscle
volume (chi-square= 15.64, p<0.001). The total knee extensor muscle volume was
reduced from 1564.6 ± 324cm3 in young to 1110.9 ± 139 cm3 in old (z= -3.56,
p<0.001) and 1063.8 ± 242 cm3 in mobility-impaired older adults (z= -2.9, p=0.002)
(Table 3). Similarly, contractile muscle volume was found to be significantly lower
(chi-square = 15.99, p<0.001) in both old (z= -3.63, p<0.001) and mobility-impaired
(z= -2.9, p=0.002) adults compared to young adults. Although the amount of noncontractile muscle tissue did increase from 90.8 ± 17cm3 in young to 103.6 ± 18 cm3
in old and 107.6 ± 19 cm3 in mobility-impaired old adults, this difference was not
statistically significant (chi-square= 3.96, p= 0.14). However, when this volume was
expressed as a proportion of total muscle volume, a significant difference between
groups was detected (chi-square= 18.96, p<0.001). Both healthy old (9.4 ±1.8%) and
mobility-impaired old adults (10.3 ± 0.8%) had a significantly higher percentage of
non-contractile muscle volume than young adults (5.9 ±1.3%) (z= -3.56, p<0.001, z=
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-2.9, p=0.002 for healthy and mobility-impaired older adults respectively). Finally, a
significant difference was identified in subcutaneous adipose tissue area in the thigh
(chi-square= 8.04, p= 0.02), which was significantly larger in both groups of older
adults compared to young adults (z= -2.18, p= 0.03, z= -2.53, p= 0.01 for healthy and
mobility-impaired older adults respectively) (Table 3).
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B

C

Figure 3. Representative sample of magnetic resonance images (MRI) of the mid-thigh. A – young (22 years old), B – healthy
old (82 years old, walking speed: 1.3 m/s), C – mobility-impaired (72 years old, walking speed: 0.69 m/s).
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Table 3. Muscle CSA and Volume in the knee extensor muscles

CSA (cm2)
Total
Contractile
Non-contractile
Volume (cm3)
Total
Contractile
Non-contractile
% Non-contractile volume
Subcutaneous adipose tissue (cm2)

Young

Old

MI

64.9 (13.4)
62.8 (13.4)
2.1 (0.7)

45.9 (6.9)*
43.4 (6.8)*
2.5 (0.7)

43.7 (10)*
41.1 (9.4)*
2.6 (0.7)

1564.6 (324)
1473.8 (315)
90.8 (17)
5.9 (1.2)

1110.9(139)*
1007.3(135)*
103.6 (18)
9.4 (1.8)*

1063.8 (242)*
956.0 (224)*
107.8 (19)
10.3 (0.8)*

114.2 (50)

141.2 (32)*

162.0 (52)*

Total CSA was reduced in healthy and mobility impaired older adults (p=0.001,
p=0.001 respectively). Contractile CSA was significantly reduced in both older adult
groups compared to young (p= 0.001, p=0.001 respectively). Young adults had
greater knee extensor volume than healthy (p<0.001) and mobility impaired older
adutls (p=0.002). Although absolute non-contractile volume did not differ between
groups (p= 0.14), when represented as a percentage of total muscle volume, both
healthy (p<0.001) and mobility-impaired older adults (p=0.002) had a significantly
greater proportion of non-contractile tissue than young adults. Both older adult
groups also had a greater amount of subcutaneous adipose tissue compared to
young adults (p= 0.03, p= 0.01 respectively). * indicates significantly different from
young. Values presented as means (standard deviation).
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3.2.4 Magnetization transfer ratio in the ankle dorsiflexors
MTR represents the change in contrast of images with off-resonance RF pulse
from those without (Figure 4) and is expressed as a ratio change from baseline per
unit (p.u.). There was a significant difference in MTR (chi-square= 17.39, p<0.001),
which was larger in young adults (0.43 p.u.) compared to healthy old (0.38 p.u., z= 3.96, p<0.001) and mobility-impaired older adults (0.41 p.u., z= -1.78, p=0.04).
Further, MTR in healthy older adults was also significantly reduced compared to
mobility-impaired adults (z= -2.28, p=0.02) (Figure 5).
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A1

B1

C1

A2

B2

C2

Figure 4. Sample of magnetic resonance images (MRI) of the lower leg with off-resonance radio frequency pulse (A1, B1, C1)
and without (A2, B2, C2). Images were taken in the same individual at the same location in the muscle. Images with offresonance pre-saturation (A1, B1, C1) appear darker as the radio frequency pulse excites protein molecules in the muscle.
MTR is calculated based on the difference in signal contrast between these two images. A – young (25 years old, MTR: 0.43), B
– healthy old (72 years old, walking speed: 1.5 m/s, MTR: 0.35), C – mobility-impaired (72 years old, walking speed: 0.96 m/s,
MTR: 0.42)
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Figure 5. MTR in young, healthy old and mobility-impaired older adults

MTR represented in percentage units of young (light grey) healthy old (dark grey)
and mobility-impaired older adults (black). Both groups of older adults had
significantly lower MTR compared to young adults (p<0.001, p=0.04 for healthy and
mobility impaired old respectively). Healthy old adults were also significantly
reduced compared to mobility-impaired older adults (p=0.02). * indicates
significant difference from young adults. † Indicates significant difference from
mobility-impaired old adults. Values presented as mean ± standard deviation
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3.3 Discussion
The objective of this study was to determine the total muscle mass, as well as
contractile and non-contractile components of the ankle dorsiflexors and knee
extensors in young, healthy older and mobility-impaired older adults. Additionally,
we explored the quality and quantity of muscle tissue in the ankle dorsiflexor
muscles using MT. Previous research has examined differences in muscle mass [3]
and MTR in healthy old [20, 21] and very old adults [21]; however, to our
knowledge no study has investigated contractile and non-contractile muscle mass as
well as MT in a group of older adults with mobility impairment compared to healthy
similarly aged older adults. This study provides evidence that older adults have less
contractile muscle mass and more non-contractile tissue within their muscles, and
that these changes may be accentuated in older adults with impaired mobility.
In the present study we found that contractile sectional muscle area in the
ankle dorsiflexors was not significantly different between groups. Yet, contractile
volume was significantly reduced in mobility-impaired older adults, but not in
healthy older adults, when compared to the young adults. As well, we observed a
two-fold increase in the amount of non-contractile tissue within the muscles of both
groups of older adults. While the actual composition of this non-contractile tissue
could not be directly measured in the present study, previous research using muscle
biopsies suggest that is it most likely comprised of fat and connective tissue [28].
Our results are in accordance with previously published studies of the ankle
dorsiflexors. Kent-Braun et al. [3] used MRI to determine the proportion of
contractile and non-contractile muscle area of the anterior compartment in young
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(26-44 years) and old (65-83 years) men and women. Similar to the present study,
the authors found that there was no difference in the total (contractile + noncontractile) area of the anterior compartment, but older adults had significantly
reduced contractile area compared to young adults. As well, the authors reported
~14% of the total muscle area was non-contractile, which was over twice as much
as the ~6% recorded in young adults. These data are remarkably similar to the ~5%
and ~10% of non-contractile tissue volume reported in the current study for young
and older adults respectively. Similarly, Moore et al [22] investigated the effects of
diabetic polyneuropathy on muscle mass in the TA muscle. They reported noncontractile muscle volume to be 15% of the total TA muscle volume in a healthy
control population (mean age: 59 years). Finally, Power et al [21] examined the
influences of aging on muscle quality in young (22-30 years), old (60-73 years), and
very old (76-85 years) males. They reported the CSA of the ankle dorsiflexors to be
15.2 cm2 in young, 14.7 cm2 in old, and 14.8 cm2 in very old adults, which is slightly
higher than the 11.0 cm2, 10.6 cm2 and 9.5 cm2 reported here for young, old and
mobility-impaired adults respectively. Similarly, the values reported for total
contractile volume in that study (235.2 cm3, 194.4 cm3, and 191.5 cm3 for young, old
and very old) was larger than those reported in the current study (Table 2.).
However, Power et al. [21] studied exclusively older males, and it has consistently
been demonstrated that males have more muscle mass than females [2, 3, 7, 10, 29,
30]. While the absolute values reported for non-contractile area in that study are
larger than those reported in this study, a similar trend was observed whereby old
(3.0 cm2) and older (3.6 cm2) adults had nearly twice as much non-contractile tissue
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as young adults (1.8 cm2). Thus, based on these results it would appear that the loss
of muscle mass and accumulation of intramuscular fats with age occurs at a similar
relative proportion in the anterior compartment of males and females.
Numerous previous studies have examined the contractile area and volume
of the knee extensor muscles. An early investigation by Trappe and colleagues [31]
used MRI to investigate the age-related atrophy of muscle mass in the four
quadriceps muscles in males and females. When separated based on sex, the authors
reported a mean CSA of 53.4 cm2 in young females, and 45.2 cm2 in old females
(mean age: 77 ± 6 years). Similarly, Melnyk et al. [32] reported a contractile area of
57.9 cm2 for young females and 45.2 cm2 for healthy older females. A longitudinal
study by Delmonico et al. [33] examined muscle strength and quality in adults
between 70 and 79 years old and reported an average quadriceps muscle area of
42.8 cm2 in a sample of 865 older females. In a group of females aged 74 ± 5 years,
Maden-Wilkinson et al. [30] reported a knee extensor contractile muscle volume of
993 cm3, which was significantly less than the 1368cm3 observed in young females.
These values are similar to those presented here (Table 3) for young, old and
mobility-impaired older females. A previous review of the literature for the knee
extensors shows an ~29% decline in muscle mass with age [34]. Indeed, when
considering total muscle mass in the current study, we observed a 29% and 32%
decline in muscle mass for the healthy old and mobility-impaired older adults
respectively. Thus, results from the present study are in agreement with previously
published data.
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Several studies have also assessed the contractile and non-contractile
components of the knee extensor muscles. Hogrel et al. [7] calculated total muscle
volume and intramuscular fat content of young (20-30 years) and older adults (7080 years). The authors found young females to have a total quadriceps muscle
volume of 1294 cm3 compared to 949cm3 in older adults. Moreover, the authors
reported intramuscular fat content to be 2.8% in young adults and 4.5% in the old.
This 1.5x increase in intramuscular fat content in older adults is similar to what was
observed in the current study. Further, another study by Chambers et al. [34]
reported an increase in IMAT percentage from 4.7% in young females to 12.3% in
older females, which is comparable to the 5.9% in young, 9.4% in old and 10.3% in
mobility-impaired older females reported in this study.
Recently, the effects of high levels of physical activity on skeletal muscle mass
and function were investigated by comparing lifelong exercisers with a group of
sedentary, but healthy, older adults [34]. The authors reported that lifelong exercise
reduced the accumulation of IMAT by 50% in males. Since it is known from
previous reports that greater amounts of IMAT leads to decline in lower extremity
function performance [9], maintaining a healthy active lifestyle may prove critical to
the prevention of mobility impairment with age. Furthermore, in 2012 Buford et al.
[6] examined lower extremity tissue components in older adults categorized by
physical performance. They separated older adults into either high functioning or
low functioning based on their score on the Short Physical Performance Battery
(SPPB). The high functioning older adults had a mean age of 76 ± 5 years of age and
a gait speed of 1.10 m/s, whereas the low functioning adults were 81 ± 4 years of
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age with a gait speed of 0.67 m/s. Similar to the present study, the authors found a
slightly higher, although not statistically different, percentage of non-contractile
muscle tissue in low functioning older adults compared to high functioning, and an
approximately two-fold increase in both older groups compared to young. In the
present study, although we observed a trend towards lower contractile muscle mass
in the knee extensors of mobility-impaired older adults (956.0 ± 224 cm3) compared
to healthy old adults (1007.3 ± 135 cm3), this difference was not statistically
significant. Buford et al. [6] on the other hand, recorded a significant decline in
contractile muscle mass in low functioning compared to high functioning older
adults. There were some key differences between these two studies, which may
explain the conflicting results. First, the study by Buford et al. [6] included both
males and females in their sample, where the current study consisted of only
females. It has been documented that age-related muscle atrophy and intramuscular
fat infiltration may affect males and females differently [2, 7, 34]. Additionally, in the
current study, we controlled for age between healthy old and mobility-impaired
older adults, whereas in their study the low functioning older adults were on
average 5 years older than the high functioning adults. A previous longitudinal study
by Frontera et al [35] found a 16% decrease in knee extensor area over a 12-year
period, indicating an approximate 1.3% loss of knee extensor area per year. That
would imply a difference in muscle mass of 6.5% over a 5-year period. Finally, the
gait speed of the individuals in the low functioning group (0.67 m/s) was
significantly slower than the gait speed reported for mobility-impaired participants
in this study (0.87 m/s). Thus, it is possible that individuals in the Buford et al. [6]
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study were more impaired than our mobility-impaired group and consequently had
greater loss of muscle mass. Together, these studies emphasize the role that
mobility plays in the quantification and classification of sarcopenia with age.
Although there is an abundance of research to support the role of muscle
atrophy and accumulation of IMAT in the development of mobility impairment with
age, it is becoming increasingly evident that SAT also significantly contributes to this
process [36]. We reported a significant increase in SAT in both groups of older
adults, with a tendency towards even greater SAT in mobility-impaired older adults
(Table 3). This increase in SAT was apparent despite no difference in height or
weight between experimental groups. Some previous research has shown no
difference in SAT area in older adults compared to young controls [6, 33]. In a
longitudinal study of muscle quality Delmonico et al. [33] found that SAT increased
only in participants who gained weight, and that individuals who lost weight also
lost SAT area. However, despite the common misconception that adipose tissue is
simply a vessel for the storage of fat, it is actually a highly active tissue responsible
for the secretion of many endocrine molecules [36]. Recent work by O’Leary and
colleagues [37] implicates greater amounts of SAT with an augmented secretion of
resistin. In turn, resistin inhibits myogenesis while also promoting intramuscular
lipid accumulation in older individuals. Adipose tissue has also been associated with
the release of pro-inflammatory cytokines [36], which may amplify the oxidative
stress and chronic inflammation experienced by motor axons leading to axonal
death and concomitant muscle fiber atrophy and loss. Additionally, it has been
shown that higher levels of total body fat predicts future incidence of mobility
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disability, even in currently high functioning individuals [38]. Thus, it is conceivable
that the significant increase in thigh SAT area observed in the present study may
have contributed to hormonal dysregulation in older adults and resultant mobility
impairment. However, further research into the effects of SAT on mobility in older
adults is needed.
MTR has been increasingly utilized in studies of skeletal muscle to assess the
quality and quantity of muscle protein. Using individuals with limb girdle muscular
dystrophy as a model, McDaniel et al. [18] were able to demonstrate that MT can
quantify pathological myogenic changes within skeletal muscle. Additionally, a more
recent investigation by Sinclair and colleagues [39] examined MTR in participants
with chronic demyelinating polyneuropathy and Charcot-Marie-Tooth disease. The
authors found that MTRs were reduced in both these groups of patients with
peripheral neuropathy compared to healthy control subjects. Finally, Moore et al.
[22] examined MT in the TA muscle of participants with diabetic polyneuropathy
compared to healthy age-matched controls and reported significant reductions in
MTR in participants with diabetic polyneuropathy. Together, these studies highlight
the efficacy of MT imaging to reflect myogenic and neurogenic changes within
skeletal muscle.
Previous studies have investigated changes in MT in the TA in older adults. In
a group of a 55-79 year old men and women, Schwenzer et al. [20] observed a nonsignificant trend towards reduced MTR in old adults (0.44 p.u.) compared to young
adults (0.47 p.u.) in the TA muscle. Power and colleagues [21] used MT to examine
muscle quantity and quality in the TA of young, old (60-73 years) and very old (76-
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85 years) men. The authors found no difference in MTR between young and old
adults; however, they reported that MTR in very old men was significantly reduced
compared to both young and old participants. They concluded that the quantity of
muscle protein may be preserved in the old population due to the compensatory
process of reinnervation in the muscle, which is eventually outpaced in the very old
population resulting in a reduction in MTR. The ~8% decrease in MTR in very old
adults compared to young reported in that study is similar to the 12% and 5%
reduction reported for healthy old and mobility-impaired older adults respectively
in the current study.
Interestingly, in the current study, although both groups of older females had
significantly lower MTR compared to young adults, our healthy older adult’s MTR
were also significantly lower than mobility-impaired older adults. This is contrary to
our hypothesis, stating that mobility-impaired adults would likely have reduced
muscle protein quality and quantity compared to healthy older adults. One possible
explanation for this observation is that the quality of the muscle fibers in the healthy
older adults may be reduced resulting in a lower MTR. As reported previously, the
total contractile volume of the ankle dorsiflexor muscles was significantly reduced
in the mobility-impaired older adults, but not in the healthy older adults, indicating
that the resultant MTR was unlikely due to a decrease in muscle quantity per se. The
reduced contractile volume observed in mobility-impaired older adults indicates
that these individuals had likely already experienced significant denervation and
muscle fiber atrophy associated with sarcopenia. The healthy older adults, on the
other hand, may be actively experiencing cycles of denervation and reinnervation
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resulting in a relative preservation of contractile muscle tissue, but a decrease in the
quality of that tissue. This theory is corroborated by results from an unpublished
study from our group denoting an increase in NF jiggle in healthy older adults, but
not mobility-impaired older adults, compared to young. As motor neurons are lost
and surviving motor axons work to recapture orphaned muscle fibers, the
characteristics of the muscle fibers are changed and the stability of the NMJ is
affected. It is possible that this may manifest as a reduction in muscle quality on MT
images, however further research investigating MTRs in sarcopenic skeletal muscle
is warranted.
Although there are many strengths to this study, it is not without some
limitations that should be considered when interpreting the results. Namely, there is
a relatively small sample size, especially in our mobility-impaired older adult group.
However, it should be noted that previous studies have been able to yield significant
results with a similar sample size [21, 22]. Still, the smaller sample size may impact
the ability for this study to find differences between groups, leading to a potential
type II error. Thus, these results of age and mobility on muscle tissue composition
should be considered a conservatively.
In conclusion, this study aimed to identify the contractile and non-contractile
components of ankle dorsiflexor and knee extensor muscle groups in young, healthy
old and mobility-impaired older adults. Further, we endeavored to investigate the
quality and quantity of muscle protein in the TA using the novel MT technique. The
results of this study show that total contractile muscle mass is lost with age, which is
accompanied by an increase in non-contractile tissue within the muscle. Moreover,
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we provide evidence that changes within skeletal muscle may be more prominent in
adults with mobility impairment. Future research into the ability of MT to identify
muscle protein quality at different stages of mobility impairment and sarcopenia is
required.
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Chapter 4
Examining specific strength and power in the lower extremity of
healthy and mobility-impaired older adults: the influence of
contraction velocity
4.0 Introduction
The loss of muscle mass and subsequent strength deficits associated with
aging has been well defined [1, 2]. However, more recently it has been identified
that, with aging, the loss of strength and function exceeds the amount of reduced
muscle mass[2-4]. This has led some to suggest that aging results in changes to the
neural and contractile properties of muscle fibers, leading to a decrease in the
amount of force produced per unit of muscle mass [2-5]. Clark and Manini [3] have
since coined the term dynapenia to refer to the loss of strength and power
associated with age, to better encompass the complexity of changes that occur
within muscle during senescence.
Power is the product of torque and velocity, and the reduction of muscular
power with age has gained increased interest from researchers over the past two
decades [4, 6-15]. Although strength is known to decrease with advanced age, it is
often well maintained until beyond 70 years of age [1, 2, 6, 16, 17]. Contractile
velocity during voluntary muscle contraction, on the other hand, has been shown to
decrease much earlier in life than strength [6, 9, 18, 19]. This reduced contraction
velocity has been linked to a preponderance of type I muscle fibers in aged muscle
as muscle biopsy studies have shown a decrease in type II fiber distribution in older
muscle [1, 20-22]. As well, previous works suggests that oxidative stress and
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chronic inflammation can damage motor neurons [5, 23], and that type II motor
neurons may be more susceptible to this process than type I motor neurons [24, 25].
An increase in the ratio of type I:II fiber area in the muscle results in a slowing of
whole muscle contractile velocity. Since power consists of the product of torque and
velocity of contraction, age-related differences in one or both of these measures can
have a cumulative effect on power production. Therefore, power may be a more
sensitive measure than the individual influence of either of its constituents.
In an experimental set up, power can be measured in one of two ways; either
the velocity is held constant and the torque produced is measured (isokinetic), or
the torque is held constant while velocity is measured (isotonic). Early work
measuring muscular power tended to focus on isokinetic power production;
however, it has been suggested that isotonic power may be more functionally
relevant to how we move, as activities of daily living (ADLs) require the movement
of a constant load (i.e. body mass) at varying velocities throughout differing ranges
of motion (ROM) to accomplish various tasks (e.g. sit-to-stand, gait, stair climbing
etc.)[6, 7]. This has led to an increase in the number of studies investigating
velocity-dependent (isotonic) muscular power [6, 7, 13, 26-28]. Many studies have
shown that velocity-dependent muscular power declines with age [6, 13, 26, 27],
and that deficits in power appear before, or to a greater extent, than the loss of
isometric strength [4, 6-8, 11]. Skelton et al. [11] have reported that leg extensor
power is lost at twice the rate of isometric strength in older adults. Additionally,
reductions in lower extremity muscle power have been associated with an increased
incidence of mobility impairment [18, 29, 30] and increased fall risk in older adults
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[31]. This has led some to suggest that exercise training programs for older adults
should aim to increase velocity-dependent torque production, rather than
traditional strength training [4, 14] (for a review of velocity-dependent power
training see McKinnon et al. [4]).
In an attempt to control for the loss of muscle mass with age, researchers
have increasingly used muscle cross-sectional area (CSA) or volume to normalize
strength measurement. This normalized value, known as specific strength (or
muscle quality), represents the strength per unit of muscle mass and conveys a
more robust quantification of strength loss with age, taking into account the
intrinsic force generation capacity of the muscle. Although not all studies agree [3234], it has been reported that specific strength declines with age [6, 10, 35-37].
While less extensively studied, specific power has consistently been shown to
decrease with age [6, 12, 15, 38-41]. A previous examination of specific strength and
power production in the ankle dorsiflexor muscles shows that while specific
strength was maintained in adults ~65 years of age, specific power was significantly
reduced [6]. As well, a previous investigation out of our lab indicates that peak
isotonic power production of the ankle dorsiflexors and knee extensors is reduced
in older adults compared to young [7], although we did not control for muscle
volume in that study. Indeed, it has been consistently shown that contraction
velocity [6, 9] and power [7, 10-13, 15, 41] are reduced in the lower extremity with
age. These studies highlight the emerging concept that muscular power is a more
sensitive and possibly meaningful measure of the changes that occur in the
neuromuscular system with age and further validates the use of power rather than
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isometric strength for assessment of sarcopenia and its impact on function in older
men and women.
Thus, the purpose of this study was to determine contraction velocity,
specific strength and power in the ankle dorsiflexor and knee extensor muscles in a
group of young, healthy old and mobility-impaired older adults to determine if
adults with impaired mobility would exhibit reduced muscle contractile velocity and
power production. Previous research suggests that reduced muscle power and
contraction velocity is associated with impaired mobility in older adults [18, 29, 30,
42] putting them at increased risk for falls, as they are less able to produce force
rapidly to counteract postural perturbations [4, 31]. Therefore, we hypothesized
that both groups of older adults would display reductions in muscle contraction
velocity compared to healthy older adults, with greater deficits recorded in
mobility-impaired older adults. Moreover, we anticipated that mobility-impaired
older adults would have a further reduction in specific power production.
4.1 Methods
4.1.1 Participants
The study sample consisted of females divided into three groups: 1) young 2)
healthy older 3) mobility-impaired older. Females 65 years or older were eligible for
one of the two older adult experimental groups. After consenting to participation in
the study, all older adults took part in a walking test using the GAITRite system (CIR
System Inc., Franklin, NJ). Participants with a gait speed of greater than 1 m/s were
classified as healthy older adults, while those with a gait speed less than 1 m/s were
categorized as mobility-impaired [43, 44]. Young participants were recruited from
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the Western University student population and were recreationally active. All
participants signed written informed consent before participating in the study,
approved by the Western University Research Ethics Board and in accordance with
the Declaration of Helsinki. All participants were free from any known
neuromuscular or musculoskeletal disorders that would significantly impact their
performance. Participants with diabetes, a recent fracture or injury, or implanted
metal device were excluded from participating in this study.
4.1.2 Repeated chair stands
Participants were asked to perform a repeated chair stand task as a measure
of functional performance. The repeated chair stands task measures the
participant’s ability to repetitively and rapidly move their body weight from a
seated to standing position and is used as part of the Short Physical Performance
Battery (SPPB). Starting from a seated position with hips and knees bent to 90° and
feet firmly on the floor, participants were asked to quickly, but safely, stand and sit
back down a total of 5 times. The experimenter counted the participants down and
started a stop watch as soon as they began their first stand and stopped the timer
once they returned to a seated position after 5 total stands.
4.1.3 Voluntary activation
The interpolated twitch technique (ITT) was used to measure voluntary
activation in the ankle dorsiflexors in this study. The ITT involves delivering a
supramaximal electrical stimulus to the motor nerve supplying the anterior
compartment during a maximal voluntary contraction (MVC) and is used to
determine the participant’s percentage of voluntary activation of the motor neuron
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pool [16, 45]. Participants were positioned in a custom-built ankle dynamometer
with their ankle fastened to a footplate at an angle of 30° plantar flexion. Adjustable
cuffs were positioned over the anterior tibia and superior surface of the knee across
the distal thigh to restrict excessive lower extremity movement during testing. The
footplate was attached to a load cell (LCDA-100, Omega Engineering Inc.,
Connecticut, USA) and amplified (1902, Cambridge Electronic Design, Cambridge,
UK) for processing in Spike 2 (Version 6, Cambridge Electronic Design, Cambridge,
UK). A bipolar stimulator was positioned over the common fibular nerve and a
series of evoked twitch responses were recorded. The experimenter increased the
intensity of the stimulus until a plateau in the twitch response was reached at which
point the stimulus was increased by an additional 15% to ensure a supramaximal
stimulation. Participants were then instructed to perform a maximal dorsiflexion
contraction during which a supramaximal stimulus was delivered during the plateau
of the MVC (interpolated twitch) and approximately one second after completion of
the MVC (resting twitch). This process was repeated twice and percentage of
voluntary activation was then calculated using Equation 1. The higher value of the
two trials was considered that participant’s percentage of voluntary activation.
Equation 1:
Voluntary activation (%) = [1 – (interpolated twitch/resting twitch)] x 100
4.1.4 Strength data collection
Strength was measured in the participant’s dominant limb using the Biodex
System 3 Dynamometer (Biodex Medical Systems, Shirley, NY) by performing an
isometric MVC. For the ankle dorsiflexors, participants were seated in the Biodex
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with their right ankle fixed to the dynamometer footplate via Velcro straps. The
ankle was positioned in 30° of plantar flexion while the knee and hip were both kept
at 90° angles. The participants were securely fastened in the Biodex with seatbelts
across the hips and both shoulders to help mitigate any excess movement during
contractions. Additionally, to help isolate torque production to the muscle under
study, participants were instructed to cross their arms over their chest during
testing to prevent additional force generation from muscles farther up the kinetic
chain. Before testing began, participants performed some light dynamic
contractions to warm up and to become familiarized with the task. Once adequately
warmed up, participants were instructed to perform a maximal isometric
dorsiflexion contraction. Participants were asked to perform a dorsiflexion
contraction by “pulling your foot/ankle up” or “bringing your toes towards your
nose” and holding that contraction for four seconds. During the contraction the
participants received verbal encouragement from the experimenter as well as visual
feedback of their force production on a computer screen. The torque produced was
recorded (in newton meters (Nm)) and this process was repeated a total of three
times, with the largest force achieved being considered the participant’s MVC. Each
contraction was separated by at least one minute of rest to reduce the effects of
fatigue. If a participant displayed large inconsistencies between consecutive MVC
attempts, additional contractions were performed, separated by one minute of rest,
until the difference between attempts was less than 5%. The same protocol was
followed to determine maximal knee extensor strength using a different attachment
to the dynamometer which strapped around the lower leg approximately 2cm
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superior to the lateral malleolus. The knee and hip joints were again positioned at
90° angles and participants were instructed to “kick out” or “straighten your knee”
with as much torque as possible.
4.1.5 Power data collection
Peak muscle power was calculated using the Biodex System 3 Dynamometer
(Biodex Medical Systems, Shirley, NY). Participants were seated in the
dynamometer as described for strength testing. As power is the product of torque
and velocity, the dynamometer was set to isotonic mode and the experimenter input
mechanical resistance equal to 1 Nm and then 10, 20, 30, 40 and 50% of the
participant’s MVC recorded during strength testing. 1 Nm was chosen because it is
the minimum load possible when selecting isotonic resistance on the Biodex.
Participants were instructed to perform two rapid dynamic contractions for each
load. Instructions were given to contract as quickly as possible concentrically and
then passively return to the starting position before again contracting as quickly as
possible against the resistance. This process was repeated for each of the six
submaximal MVC loads, and the higher of the two contraction attempts was used as
the peak power produced at that load. To help reduce any potential practice effects,
the order in which the participants performed each contraction was randomly
selected before commencement of the study. The experimenter provided verbal
encouragement during power testing, as well as visual feedback on a computer
screen. Previous research has confirmed this procedure to be a reliable measure for
determining isotonic velocity-dependent power [46, 47].
4.1.6 Strength & power analysis
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During both strength and power testing torque and velocity data from the
Biodex were amplified (Power1401-3A, Cambridge Electronic Design, Cambridge
UK) and collected by Spike 2 (Version 6, Cambridge Electronic Design, Cambridge,
UK). Torque and velocity of muscle contractions were displayed in real-time on a
computer monitor. Muscular strength (MVC) was calculated during the data
collection process, as it was required to determine submaximal loads for power
testing. Maximal strength was determined by placing a marker over the plateau of
the participant’s isometric MVC. The highest value achieved by the participant was
recorded as their MVC (provided it did not differ by more than 5% of subsequent
MVCs as described above). During offline analysis, the experimenter used markers
to determine the peak velocity achieved for each submaximal isotonic contraction.
The values were inputted into Microsoft Excel and multiplied by the respective
isotonic resistance to determine muscular power. The highest power value achieved
across the six isotonic loads was considered the participant’s peak power. Specific
strength and specific power were determined by dividing the participants MVC and
peak power by the volume of contractile muscle mass as determined by magnetic
resonance imaging (MRI)
4.1.7 MRI and analysis
Using a Dixon technique with fat suppression, a 3T MRI scanner (Magnetom
Verio, Siemens Healthcare, Erlangen, Germany) acquired images of the ankle
dorsiflexor and knee extensor muscles. Positioned supine on the MRI table,
participants were moved into the bore of the magnet feet first. For the ankle
dorsiflexors, a radio frequency (RF) coil was positioned over the lower leg from the
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tibial plateau to the malleoli. The entire length of the anterior compartment was
imaged with a repetition time (TR) of 3000ms, echo time (TE) of 11ms and flip angle
of 180° and a slice thickness of 5mm with no slice separation. The same protocol
was followed for the knee extensor muscles except two RF coils were used to span
the entire length of the thigh from the anterior superior iliac spine to the joint line of
the knee.
OsiriX DICOM viewer (Version 11.0.2, Prixmeo SARL, Geneva, Switzerland)
was used for all MRI analysis. The semi-automated process for the calculation of
muscle volume was described in detail in Chapter 3. Briefly, a region of interest
(ROI) containing only the muscles under study was manually outlined on every
third image beginning distally and working proximally. Computer software was then
used to create ROIs on the rest of the images based on the manually outlined areas.
These ROIs were then used to render a three-dimensional (3-D) model of the muscle
and the “total” muscle volume. Using the brush tool, the experimenter then
subtracted any fat, connective tissue, neurovascular tissue or septal spaces from
each image and calculated the volume as the muscle “contractile” volume. The same
experimenter analyzed all the images for this study. For the knee extensors, there
was some overlap of images due to the use of two RF coils. For these images, the
experimenter viewed the area of overlap side-by-side in a viewing window and
eliminated the duplicates with poorer signal quality. Participant’s contractile muscle
volume (Table 1) was used to calculate specific strength and power.
4.1.8 Statistics
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Differences between groups were determined using a Kruskal Wallis H test.
Post-hoc testing consisted of individual Mann-Whitney U tests with a modified
Bonferonni correction to account for inflated alpha error. A two-way repeated
measures analysis of variance (ANOVA) was used to investigate potential
differences in power production at different loads. Experimental group (young,
healthy old, mobility-impaired old) was set as between-groups factors, while
submaximal isotonic load (1Nm, 10, 20, 30, 40, 50% MVC) was considered the
within-group variable. A similar analysis was conducted for contraction velocity
with factors of experimental group (between groups variable) and isotonic load
(within-group variable). If a significant difference was detected, post hoc analysis
consisted of Tukey’s test, with a Bonferroni correction for multiple comparisons. All
values are presented as means ± standard deviation. Statistical Package for the
Social Sciences (Version 21; IBM SPSS Inc., Chicago, IL) was used for all statistical
testing with a significance level of p≤0.05.
4.2 Results
4.2.1 Participants
A total of 30 females took part in this study. There was no difference in
height (chi-square= 3.38, p=0.185) or weight (chi-square= 6.19, p=0.056) between
young (n=12, mean age: 25 ± 2 years), healthy old (n=11, mean age: 74 ± 6 years) or
mobility-impaired older adults (n=7, mean age: 72 ± 5 years). Healthy older females
had a significantly faster gait speed (1.26 m/s) than mobility-impaired adults (0.89
m/s) (z = -3.49, p<0.001). A significant difference in contractile muscle mass was
detected between groups (chi-square= 8.43, p= 0.015, chi-square= 16.0, p<0.001 for
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ankle dorsiflexors and knee extensors respectively). Mobility-impaired older adults
had significantly less ankle dorsiflexor contractile muscle volume compared to
young adults (z= -2.62, p=0.007). Both groups of older adults had significantly less
knee extensor muscle volume compared to young adults (z= -3.63, p<0.001, z= -2.9,
p= 0.002 for healthy and mobility-impaired older adults respectively). Participant
demographics are presented in Table 1
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Table 1. Participant Demographics

Sample size
Age (years)
Height (cm)
Weight (kg)
Gait Speed (m/s)
Repeated Chair Stands (seconds)
AD contractile muscle volume (cm3)
KE contractile muscle volume (cm3)

Young

Old

MI

12
25 (2)
165 (5)
63.4 (13)
6.8 (0.9)
206.6 (35.9)
1473.8 (315)

11
74 (6)*
164 (5)
71.5 (8)
1.26 (0.17)
10.7 (2.3)*
181.6 (22.4)
1007.3 (135)*

7
72 (5)*
161 (4)
79.5 (21)
0.89 (0.10)*
13.9 (4.6)*†
162.2 (28.2)*
956.0 (224)*

AD: ankle dorsiflexor, KE: knee extensor. *indicates significantly different from
young. † indicates significantly different from healthy old.
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4.2.2 Repeated chair stands
All participants were able to complete all 5 sit-to-stands, but there was a
statistically significant difference between time taken to complete the task (chisquare= 22.1, p=0.02). Young females completed the repeated stands task
significantly quicker than healthy (z= -4.05, p<0.001) and mobility-impaired older
females (z= -3.47, p=0.001). Further, mobility-impaired older females were also
significantly slower at completing the 5 sit-to-stands than healthy older adults (z= 2.16, p=0.031) (Table 1).
4.2.3 Voluntary activation
There was no difference in percentage of voluntary activation as recorded by
the ITT (chi-square= 1.33, p=0.513). All participants were able to achieve greater
than 99% activation in the ankle dorsiflexor muscles.
4.2.4 Isometric strength
Kruskal Wallis testing indicated there was a significant difference in strength
between groups (chi-square= 6.57, p=0.037). Post hoc analysis determined there
was no difference in isometric strength between young and healthy old participants
in the ankle dorsiflexor muscles (z= -1.85, p=0.069); however, mobility-impaired
older adults were significantly weaker than young adults (z= -2.2, p=0.028). In the
knee extensor muscles isometric strength was significantly reduced (chi-square=
10.27, p=0.006) in both groups of older adults compared to young adults (z= -2.55,
p=0.009, z= -2.58, p= 0.007 for healthy and mobility-impaired old respectively), but
was not different (p=0.16) between mobility-impaired (72 ± 24 Nm) and healthy
older adults (85 ± 14 Nm)(Table 2).
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4.2.5 Velocity of contraction and power
There was no interaction effect detected for contraction velocity in the ankle
dorsiflexors (F (10,130)= 1.11, p= 0.365). However there was a significant main
effect of velocity (F (5,130)= 312.1, p<0.001) and group (F (2,26)= 10.7, p= <0.001).
Post hoc testing determined there was a significant difference between young and
healthy old (p=0.01), young and mobility-impaired old (p=<0.001) but not between
healthy old and mobility impaired older adults (p=0.063). Although mobilityimpaired older adults were on average slower than healthy older adults under all
six-test conditions, this difference was not statistically significant (p>0.05) (Figure
1).
There was a significant interaction effect between groups on knee extension
contraction velocity (F (5,10)= 2.44, p=0.028). Knee extensor contraction velocity
was significantly reduced in mobility-impaired older adults compared to young
adults at each submaximal load (p= 0.01, <0.001, <0.001, <0.001, <0.001, <0.001, for
1Nm-50% MVC respectively). Additionally, mobility-impaired older adults knee
extensor contraction velocity was also significantly slower than healthy older adults
at 1 Nm (p= 0.04), 10 (p= 0.023), 30 (p= 0.008) and 40% MVC (p= 0.015). Healthy
older adults were significantly slower than young adults in the 20 (p= 0.02), 30 (p=
0.03), 40 (p= 0.01) and 50% MVC (p= 0.03) test conditions (Figure 2).
A significant difference was detected between groups for peak isotonic
power in the ankle dorsiflexors (chi-square= 16.0, p<0.001) and knee extensors
(chi-square= 16.6, p<0.001). Peak isotonic power was reduced in mobility-impaired
older adults compared to young and healthy older adults in the ankle dorsiflexors
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(z= -3.5, p= 0.001 z= -3.3, p= 0.001 for young and healthy old respectively). There
was no difference in peak power between young and healthy older adults (z- 1.6,
p=0.1). (Table 2). In the knee extensors both healthy (z= -2.5, p=0.014) and
mobility-impaired older adults (z= -3.5, p=0.001) produced significantly less power
than young adults, with mobility-impaired adults also producing significantly less
power than healthy older adults (z= -2.8, p=0.006). Results for isometric strength
and peak power are summarized in Table 2.
When peak power in the ankle dorsiflexors was assessed at each of the six
submaximal isotonic loads a significant interaction effect was detected (F (10,125)=
8.9, p<0.001). Post-hoc testing determined that young were significantly more
powerful than mobility impaired older adults at all test conditions (p= <0.001, 0.02,
0.02, 0.01, 0.01 <0.001 for 1Nm-50% MVC respectively). Healthy older adults also
produced more power than mobility-impaired older adults at all test conditions (p=
0.003, 0.047, 0.02, 0.04, 0.008 for 1Nm, 20, 30, 40 and 50% MVC respectively)
except for 10% MVC (p=0.11) (Figure 3). There was no statistically significant
difference between young and healthy older adults at any of the 6 submaximal test
conditions (p= 0.33, 1.0, 0.4, 0.53, 0.25, 0.23 for 1 Nm-50% respectively).
A significant interaction effect was detected in the knee extensors (F
(10,125)= 13.2, p= <0.001). Mobility impaired older adults produced significantly
less power than young adults at all submaximal loads (p = 0.01, p= 0.02, <0.001,
<0.001, <0.001, <0.001, for 1Nm-50% respectively). Similarly, healthy older adults
had significantly reduced knee extensor power at 30 (p= 0.02), 40 (p= 0.03) and
50% (p= 0.03) MVC compared to young adults. Mobility-impaired older adults also
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produced significantly less power than healthy older adults at all test conditions (p=
0.03, 0.02, 0.01, 0.08, 0.02 for 1Nm, 20, 30, 40, 50% MVC respectively) except 10%
MVC (p=0.052)(Figure 4).
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Table 2. Isometric muscle strength and peak power in young, healthy old and
mobility-impaired older adults

Ankle Dorsiflexors
MVC (Nm)
Power (W)
Knee Extensors
MVC (Nm)
Power (W)

Young

Old

MI

30 (7)
23 (7)

25 (4)
19 (6)

21 (8)*
8 (4)*†

107 (24)
298 (75)

85 (14)*
210 (81)*

72 (24)*
93 (56)*†

* Indicates statistically significant difference from young. † indicates significantly
different from healthy older adults. Values presented as mean (standard deviation).
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Figure 1. Ankle dorsiflexor contraction velocity
No interaction effect was detected for contraction velocity in the ankle dorsiflexors
(p= 0.365). A significant main effect of group (p<0.001) showed that young adults
(diamonds) were significantly faster than healthy old (squares)(p=0.01) and
mobility-impaired older adults (triangles)(p<0.001). There was no difference
between healthy and mobility-impaired older adults (p=0.063). Values presented as
mean ± standard error.
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Figure 2. Knee extensor contraction velocity
A significant interaction was detected between group and isotonic load (p=0.028).
Mobility-impaired (triangles) older adults had a significantly reduced contraction
velocity compared to young adults (diamonds) at every submaximal load (p= 0.01,
<0.001, <0.001, <0.001, <0.001, <0.001, for 1Nm-50% MVC respectively). Mobility
impaired older adults were also significantly slower than healthy older adults at the
1 Nm (p= 0.04), 10 (p= 0.023), 30 (p= 0.008) and 40% MVC (p=0.015) test
conditions. Healthy older adults (squares) had a slower contraction velocity than
young adults at 20 (p= 0.02), 30 (p= 0.03), 40 (p= 0.01) and 50% MVC (p= 0.03). *
indicates significant difference from young. † indicates significantly different from
healthy old. Values presented as mean ± standard error.
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Figure 3. Ankle dorsiflexor power at submaximal isotonic loads
A significant interaction effect was detected (p<0.001). Young adults (diamonds)
produced significantly more power than mobility impaired older adults (triangles)
at al test conditions (p= 0.003, 0.047, 0.02, 0.04, 0.008 for 1Nm, 20, 30, 40 and 50%
MVC respectively). Mobility-impaired older adults also produced less power than
healthy older adults (squares) at all test conditions (p= 0.003, 0.047, 0.02, 0.04,
0.008 for 1Nm, 20, 30, 40 and 50% MVC respectively) except for 10% MVC (p=0.11).
There was no difference between young and healthy older adults,(p= 0.33, 1.0, 0.4,
0.53, 0.25, 0.23 for 1Nm-50% MVC respectively). * indicates significant difference
from young. † indicates significantly different from healthy old. Values presented as
mean ± standard error.
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Figure 4. Knee extensor power at submaximal isotonic loads
There was a significant interaction effect between group and isotonic load
(p<0.001). Mobility-impaired older adults (triangles) produced significantly less
power than young adults (diamonds) under all test conditions (p= 0.01, 0.02,
<0.001, <0.001, <0.001, <0.001, for 1Nm-50% respectively). Mobility-impaired older
adults also produced less power than healthy older adults (squares) at 1Nm
(p=0.03), 20 (p=0.02), 30 (p=0.01), 40 (p= 0.008) and 50% MVC (p= 0.02). Healthy
older adults produced less power than young adults at 30, 40 and 50% MVC (p=
0.02, 0.03, 0.03, respectively) * indicates significant difference from young. †
indicates significantly different from healthy old Values presented as mean ±
standard error.
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4.2.6 Specific strength and power
Specific strength was calculated by dividing the participants MVC by their
total contractile muscle volume and is represented as Nm/cm3. Similarly, specific
power was determined from the participant’s peak power output relative to their
total contractile muscle volume in units of W/cm3. There was no difference in
specific strength between young, healthy old or mobility-impaired older adults in
the ankle dorsiflexors (chi-square= 2.47, p=0.291) (Figure 5) or knee extensor (chisquare = 4.67, p=0.097) (Figure 6) muscle groups. Specific power, however,
demonstrated a significant difference between groups in both muscles tested (chisquare= 11.6, p= 0.003 chi-square= 11.4, p= 0.002 ankle dorsiflexors and knee
extensors respectively). Specific power was significantly reduced in the ankle
dorsiflexors in mobility-impaired older adults compared to young and healthy older
adults (z= -3.2, p= 0.002, z= -2.3 p= 0.02 respectively), but there was no difference
between young and healthy older adults (z= -1.7, p= 0.09). A similar trend was
observed in knee extension specific power, where both young and healthy older
adults produced more power than mobility-impaired older adults (z= -3.1, p=0.002,
z= -2.7, p= 0.007) but did not differ from each other (z= -099, p=0.3)
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Figure 5. Specific strength and power of the ankle dorsiflexors
There was no difference between young (black), healthy old (dark grey) and
mobility-impaired older adults (light grey) in specific strength (p=0.291). Specific
power was reduced by 55% in mobility-impaired older adults compared to young
and healthy older adults. There was no difference in specific power (p= 0.09)
between young and healthy older adults. * indicates significantly different from
young. † indicates significant difference from healthy old. Values are presented as
means ± standard deviation.
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Figure 6. Specific strength and power of the knee extensors
There was no difference in specific strength between young (black), healthy old
(dark grey) and mobility-impaired older adults (light grey) (p=0.097). Specific
power was reduced in mobility-impaired older adults by 55% compared healthy old
and 50% compared to young adults. * indicates significantly different from young. †
indicates significant difference from healthy old. Values are presented as means ±
standard deviation.
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4.3 Discussion
This study aimed to examine the differences in the loss of isometric strength
and velocity-dependent isotonic power in the lower extremity of young, healthy old
and mobility-impaired older adults. Moreover, we sought to determine muscle
quality by calculating specific strength and power in these three groups. We found
that while strength was maintained in the ankle dorsiflexors of healthy older adults,
it was significantly reduced compared to young in mobility-impaired older adults.
As well, isometric knee extensor strength was reduced in all older adults compared
to young adults. Additionally, we observed a decrease in contraction velocity with
age, which was further attenuated in the knee extensors of mobility-impaired older
adults. Further, we found that peak power production was significantly lower in
mobility-impaired older adults for the ankle dorsiflexors, and both groups of older
adults for the knee extensor muscles. Mobility-impaired older adults produced
significantly less power than healthy older adults in both muscle groups tested.
Finally, similar to previous research we observed no difference in specific strength
between experimental groups [33, 34, 48], but significant reductions in specific
power [6, 12, 15, 38-41] in mobility-impaired older adults compared to young and
healthy old adults. The results of this study further validate the use of power, rather
than isometric strength, as a more sensitive measure of neuromuscular changes
with aging. As well, it underscores the importance of muscle contraction velocity in
the determination of functional mobility and muscular power production.
In the present study older adults were categorized into different groups
based on their functional mobility. While mobility-impaired older adults were the
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same age as healthy older adults, they had significantly slower average walking
speed (0.89 ± 0.10 m/s) compared to healthy old adults (1.26 ± 0.17 m/s). Previous
research has defined a gait speed of less than 1 m/s to represent mobility disability,
with individuals below this cutoff having increased risk of negative health
consequences related to their impaired mobility [43, 44, 49, 50]. Moreover, while
both groups of older females in this study were slower in performing the repeated
chair stand task compared to young adults (6.8 ± 0.9 seconds), mobility-impaired
older females (13.9 ± 4.6 seconds) were also significantly slower compared to
healthy older females (10.7 ± 2.3). These results provide validation for our
classification of participants in this study; while there was no difference in age
between the two older adult groups, mobility-impaired older females performed
significantly worse on measurements of functional mobility compared to healthy
older females.
We found no difference in voluntary activation of the ankle dorsiflexor
muscles between young, healthy old or mobility-impaired older adults. Our results
are in agreement with previously published data of central activation in the tibialis
anterior muscle with age [6, 16, 51]. Our results indicate that all the participants in
this study were able to fully recruit their available motor unit pool, and that it is
unlikely that central activation played a role in the observed loss of strength.
Therefore, deficits in strength and power most likely reside in some combination of
peripheral impairments.
When peak isometric strength was normalized to total contractile muscle
volume, there was no difference between groups in either the ankle dorsiflexors or
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knee extensor muscles. Conversely, specific power in both the ankle dorsiflexors
and knee extensors was significantly reduced in mobility-impaired older adults
when compared to young and healthy older adults. These observations is in line
with previous work, which has shown equivocal results in the measurement of
specific strength with age [10, 32-37], but unanimously reports reductions in
specific power [6, 12, 15, 38-41]. A previous study by McNeil et al. [6] examined
specific strength and power production in a group of young, old (mean age: 65
years), and very old men (mean age: 84 years) and found that while absolute and
specific strength was maintained in old men compared to young, very old men had
significant deficits in both strength measures. Further, the authors found that
absolute and specific power was reduced in both groups of older adults compared to
young, with very old adults also producing significantly less power compared to old
adults. The results of that study are in accordance with those presented here,
whereby there was no difference in specific strength between groups, but significant
reduction in specific power, at least in mobility-impaired older adults. In this study
we observed a 55% decrease in specific power in the ankle dorsiflexors, and 50% in
knee extensor specific power in mobility-impaired older adults compared to young
adults.. These values are higher than previous works that have reported reductions
in specific power of 25% in the ankle dorsiflexors and 25-41% in the knee extensors
of healthy older adults [6, 9].
Similar to previous work, we found that isometric strength was preserved in
the ankle dorsiflexors of healthy older adults. Many studies have reported that
isometric strength is well maintained into the eighth decade [6, 16, 51, 52], with

123

significant deficits in strength beginning to manifest in the late 70s and into the
early 80 years of age [6, 16]. However, contrary to these studies we observed a
significant loss of isometric strength in our mobility-impaired older adult group
who had a mean age of just 72 years. Notably, the mobility-impaired older adults
also had significantly less contractile muscle mass, so when isometric strength was
normalized to total contractile muscle volume, although mobility-impaired adults
were 19% weaker than healthy older adults, the difference was not statistically
significant. Still, the reduced isometric strength and decline in muscle volume
observed in the mobility-impaired older adults in this study is interesting
considering previous studies show no decline in strength in similarly aged adults
[16, 51]. Clearly, despite a lack of any known neuromuscular or musculoskeletal
dysfunction that may affect their strength and mobility, the mobility-impaired older
adults in this study differ from the older adults typically used in studies of aging and
sarcopenia.
Contrary to isometric strength, peak power was reduced in the knee extensor
muscle group of mobility-impaired older adults. Based on our results it appears that
peak power production was more impaired in the knee extensor muscles than it was
in the ankle dorsiflexors. McNeil and colleagues [6] previously reported a ~25%
decline in peak power in the ankle dorsiflexors, which increased to ~60% in very
old participants. Despite being similar in age to the old subjects in the McNeil et al.
study, our mobility-impaired older adults displayed a 47% decline in peak power
compared to young. Similarly, in a study investigating peak power production in the
knee extensors, Van Driessche et al. [13] reported a decline in peak power of 24-
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37% in healthy older adults with a mean age of 68 years. This is in line with peak
knee extension power observed in healthy older adults in this study (30% decrease
compared to young), but substantially less than the 69% reduction in mobilityimpaired older adults. Thus, it appears that muscle peak power production is
severely compromised in mobility-impaired older adults and may more closely
resemble that of adults over the age of 80. Further, larger more proximal muscles
such as the knee extensors, which are responsible for tasks that have a greater
demand for power, may be more affected by the adverse adaptations to muscle with
age.
When looking at peak power produced at different submaximal isotonic
loads some interesting differences can be noted. While young and healthy older
adults continue to increase in power production up to the 50% MVC test condition,
it appears that for both the ankle dorsiflexors and knee extensors mobility-impaired
older adults begin to level off in power production at around 30% MVC. Although no
previous study has examined mobility-impaired older adults with this testing
protocol, the trends observed in this study for young and healthy older adults are
similar to those previously published for the ankle dorsiflexors [6, 7] and knee
extensors [7, 13]. Mobility-impaired older adults also produced significantly less
power than healthy older adults at all test conditions except for 10% MVC for both
muscle groups tested. As well, it is particularly noteworthy that for both muscle
groups tested there was little change in the amount of power produced by mobilityimpaired adults between isotonic loads of 30-50% MVC. As power was determined
isotonically, velocity was the varying factor. Therefore, it appears that mobility-
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impaired older adults were unable to maintain relative contraction velocity as
isotonic load increased. This has significant functional consequences for mobility, as
a person’s body weight, which represents an isotonic load during activities of daily
living, tends to remain the same or even increase with age [53]. The inability of
these older adults to maintain contraction velocity at higher isotonic loads may
explain their impaired mobility. These findings underscore the growing paradigm
that exercise programs for older adults should specifically emphasize velocitydependent muscle contractions and focus on functional tasks that require strength
and power [4, 14]
It has been well documented in the literature that muscle contractile velocity
decreases with age [2, 6, 9, 13, 15, 54, 55]. Indeed, we observed a significant
reduction in contraction velocity in both healthy and mobility-impaired older adults.
Contraction velocity tended to be more impaired in older adults at higher isotonic
loads. Further, mobility-impaired older adult knee extension velocity was also
significantly slower than healthy older adults at loads of 1 Nm, 10, 30 and 40% MVC.
The pattern towards slower contraction velocity at increased isotonic loads is
similar to those presented previously in the ankle dorsiflexors [6] and knee
extensors [9, 13, 54]. A previous review examining velocity-dependent power in
older adults reports contraction velocity is reduced between 15-40% in older adults
[2]. When pooling our results from both groups of older adults, we observed a
decrease in maximal contraction velocity (Vmax) of 19% in the ankle dorsiflexors
and 20% in the knee extensors compared to young adults, which is in accordance
with the range reported previously. Sayers et al. [55] have shown that lower
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extremity contraction velocity is significantly associated with reduced gait speed
and performance on the SPPB and Van Roie et al. [28] have previously reported that
contraction velocity is the single best predictor of functional performance in older
adults. The results presented here support this supposition, as knee extensor
contraction velocity was significantly slower in mobility-impaired older adults
compared to healthy older adults. Although it is a fundamental property of muscle
that contraction velocity decreases as the force that must be overcome increases
[56], young adults dorsiflexion contraction velocity was reduced from 2.5 rad/s at
Vmax to 1.5 rad/s at 50% MVC, a difference of 40%. Dorsiflexion contraction
velocity declined by 45% in healthy older adults and 51% in mobility-impaired
adults. The knee extensors had a total loss of contraction velocity of 25, 38 and 43%
for young, old and mobility-impaired older adults respectively. Although many have
pointed towards a change in muscle fiber composition with age and an increase in
the type I:II ratio as a primary factor in reduced contraction velocity [2, 14, 20], this
does not necessarily explain the significant decline observed in the ankle
dorsiflexors, as the tibialis anterior is composed primarily of slow twitch muscle
fibers (~80%) [57, 58]. Furthermore, studies of single muscle fibers have also
reported a slowed contractile velocity in old muscle fibers [2]. This suggests that
there are intrinsic changes within the muscle fiber itself which influence the loss of
velocity and power observed with age. Indeed, molecular studies of aged myofibers
have revealed a reduction in the concentration of myosin [59] as well as a decrease
in the filament sliding speed [60]. As well, even when controlling for activity levels,
older adults have been shown to have decreased fascicle length and pennation
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angles compared to young adults [61, 62]. These changes to muscle architecture
may negatively affect mechanical properties of older muscle such as the forcevelocity relationship [4]. Additionally, the influence of antagonist co-activation [49,
63, 64], as well as slowed conduction velocity in peripheral nerves [65-67] on
muscle contraction velocity and power generation cannot be ruled out. Previously,
declines in lower extremity power have been associated with increased falls risk
[31], and Kemoun et al. [68] have reported that delayed response of dorsiflexion
contraction can predict falls. Thus, it appears that reduced muscle strength and
power with age is not simply the result of lost muscle mass, but is a more complex
interaction of changes that occur within individual muscles fibers and the
neuromuscular system as a whole with age and this has significant consequences on
an individual’s functional performance.
Many previous studies have associated declines in lower extremity power
with poor functional performance [14, 18, 28-30, 42, 55]. For the present study we
chose the ankle dorsiflexors and knee extensors as a model for aging and mobility
impairment due to their specific roles during gait and functional mobility tasks as
well as their extensive use in previous works from which a comparative analysis
could be drawn [6, 7, 13, 15, 41]. Additionally, although both muscles have been
used to model neuromuscular change, they differ in both their function [69, 70] and
relative fiber composition [57, 58, 71, 72], allowing for a more holistic view of
power and mobility loss with age. Velocity is the critical determinant in muscle
power loss and our results show that the knee extensor muscles seem to have
greater deficits in contraction velocity, and subsequently power, than the ankle
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dorsiflexors. The greater decline observed in the knee extensor muscle may be
explained by muscle fiber composition. As mentioned previously, the dorsiflexor
muscles are primarily slow twitch muscle fibers [57, 58]. The knee extensors on the
other hand have a much more heterogenous muscle fiber composition [71, 72].
Since type IIA and IIX muscle fibers are between 3-9x stronger and faster
contracting than type I fibers [2], and type II fibers represent a greater proportion of
the knee extension muscles, deficits in contraction velocity may be amplified in the
knee extensors. This has significant functional consequences considering the role of
the knee extensors for large powerful movement tasks.
To our knowledge only two previous studies have investigated similar
measures of strength and power in a group of mobility-impaired older adults [15,
41]. Similar to the results presented here, Clark et al. [15] reported a significant
decrease in peak power and specific power in mobility-impaired older adults
compared to middle-aged adults. The authors also reported a further decline in peak
and specific power in mobility-impaired adults compared to healthy old adults.
Another study lead by the same group [41] reported a decrease in muscle area as
well as peak power in mobility-impaired older adults. As well, they reported no
difference in specific strength, but significant reduction in specific power in both
groups of older adults. Similar to our results, Reid et al. [41] observed a significant
reduction in peak power in mobility-impaired older adults compared to healthy
older adults. In the present study, mobility-impaired older adults were matched in
age to healthy older adults. While all older adults were aged between 70-85 years in
the Clark et al. [15] and Reid et al. [41] studies, healthy older adults had a mean age
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of 74 ± 4 years, whereas mobility-impaired older adults were significantly older at
78 ± 5 years. It is possible that a significantly older mobility-impaired group may
have contributed to their findings since previous research shows that lower
extremity power is lost at a rate of 3% per year in males and 1.7% per year in
females [11]. However, we controlled for age in the current study, provided further
evidence that impaired mobility is associated with reduced muscular power
regardless of age. To our knowledge this is the first study to investigate velocitydependent power production in mobility-impaired older adults who were agematched to similar healthy older individuals. Further longitudinal studies are
required to delineate how these adults with early onset mobility limitation progress
with age.
In conclusion, the results of this study demonstrate that contraction velocity
seems to be the regulatory factor in determining muscle power, and it appears that
older adults with mobility impairment may be less able to maintain contraction
velocity than healthy age matched older adults. Moreover, this study provides
further evidence that muscular power is reduced in older adults even when
controlling for contractile muscle volume. Further research into mobility-impaired
older adults is necessary to delineate the exact mechanisms that lead to deficits in
contraction velocity and power.
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Chapter 5
General Discussion and Summary
5.0 General Discussion
The objective of this thesis was to examine nerve and muscle function as well
as muscle mass and quality of young, healthy old and age-matched mobilityimpaired older adults in an attempt to identify which neuromuscular factors may
contribute to mobility loss with age. By investigating two muscle groups in the
lower extremity with different roles during gait and mobility [1, 2], length of
peripheral nerve supply and muscle fiber composition [3-6], we were able to outline
a comprehensive analysis of how muscles in the lower extremity vary with age and
mobility impairment. The objectives were accomplished through a series of three
studies investigating different aspects of the nerves (Chapter 2), muscles (Chapter
3) and muscular performance (Chapter 4) in the ankle dorsiflexors and knee
extensors in healthy older females, and in females with mobility impairment.
In Chapter 2 we used quantitative electromyography (EMG) analysis to
assess motor unit (MU) properties in the tibialis anterior (TA) and vastus medialis
(VM) muscles. Based on our derived motor unit number estimate (MUNE) from the
TA muscle, it appears that mobility-impaired older adults had a greater loss of MUs
compared to healthy young adults. Additionally, measures of near-fiber (NF) jiggle,
which represent neuromuscular junction stability [7, 8], showed that the TA muscle
was more affected with age than the VM muscle. This is in accordance with previous
research, which has suggested that distal muscles may be more greatly affected by
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neuromuscular changes with age than proximal muscle groups [9-11]. This study
revealed differences in MU properties present between mobility-impaired older
adults and young adults, that are not present in similarly aged healthy adults.. This
difference may be the result of mobility-impaired older adults having an augmented
loss of MUs in their TA muscle. This has significant implications for functional
performance as previous research has shown impaired dorsiflexor function to be
associated with increased fall risk [12].
Chapter 3 explored differences in muscle mass of the ankle dorsiflexor and
knee extensor muscle groups using magnetic resonance imaging (MRI). We were
also able to determine the contractile and non-contractile muscle tissue components
using state of the art technology in MRI resolution capabilities. Our results
demonstrate that while contractile dorsiflexor muscle volume was maintained in
healthy older adults compared to young adults, it was significantly reduced in
mobility-impaired adults. As well, we observed a two-fold increase in the amount of
non-contractile tissue within the ankle dorsiflexors of both older adult groups
compared to young adults. For the knee extensors, contractile muscle volume was
significantly reduced and the percentage of non-contractile tissue volume increased
in both groups of older adults compared to young adults. The results of this study
provide further evidence of the loss of muscle tissue with age, and indicate, at least
in the ankle dorsiflexors, that mobility-impaired older adults have a greater loss of
muscle mass than young adults, which was not present in healthy similarly aged old
individuals.
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In Chapter 3 we also examined the quantity and quality of muscle protein in
the TA muscle using the novel magnetization transfer (MT) technique. The offresonance radio frequency pulse saturates water-bound protein molecules, allowing
for an analysis of the quality of contractile tissue in muscle [13, 14]. Our results
were in accordance with previously published data on MT and aging skeletal muscle,
showing a decrease in the magnetization transfer ratio (MTR) in both groups of
older adults compared to young adults. However, contrary to our hypothesis,
healthy older adults had a significantly lower MTR than mobility-impaired older
adults. We postulated that the reduced MTR in healthy older adults may be
associated with an ongoing process of denervation and reinnervation of muscle
fibers, leading to a reduction in the quality of nascent MUPs. In contrast, mobilityimpaired older adults who have already experienced significant MU loss in the TA
(as evidenced in Chapter 2), may have eliminated some of their poor quality MUs
leaving more relatively stable, higher quality units remaining. However, there is a
paucity of research on MT applied to skeletal muscle health, and further research
into how MTR is affected by alterations in nerve and muscle health is warranted.
Chapter 4 focused on how all of the above noted changes to the
neuromuscular system manifest in deficits in strength, power and functional
performance. Specifically, we examined the differences between loss of strength and
deficits in muscle power, while controlling for total contractile muscle volume. The
results of this study showed that peak muscle power was more sensitive to changes
in the neuromuscular system than isometric strength. As well, while specific
strength was maintained in both groups of older adults, specific power was reduced
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in both the dorsiflexors and knee extensors of mobility-impaired older adults
compared to young and healthy similarly aged females. Also of note, contraction
velocity appears to be the critical factor in the determination of muscular power,
and older adults with mobility impairment had significantly slower knee extension
contraction velocity than similarly aged healthy older adults. This result is
significant, as previous work has suggested that a slowed or delayed muscle
response increases the risk of falls [12, 15]. Thus, not only are mobility-impaired
older adults able to produce less power, but they may also be at a higher risk for
falls and fall-related injury due to a slowed rate of force generation.
Together these studies highlight the changes within the neuromuscular
system with age and how those changes are associated with a person’s mobility
status. Our results demonstrate that despite being similar in age and having no
obvious neuromuscular or musculoskeletal disorders, some older adults undergo
more maladaptive changes in their nervous system and muscles than others. As
well, we have shown that even when controlling for muscle mass, these changes still
exist, indicating that they must arise from intrinsic changes to the contractile
properties of individual muscle fibers. Our results are in line with previous research
indicating sarcopenia is not as simple as a linear loss of muscle mass and
subsequent strength [16-18]. Additionally, this work supports the growing
paradigm that sarcopenia exists on a continuum of impairment, and for the
purposes of research, participants should be classified into different categories of
sarcopenia based on strength, muscle mass, and functional impairment [19].
5.1 Limitations
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All of the studies in this dissertation had a relatively small sample size,
especially for mobility-impaired older adults. Therefore, the consequence is a
reduction in power to find statistically significant effects and the results should be
considered conservatively. The mobility-impaired participants were particularly
difficult to recruit as they had to be impaired enough to meet the inclusion criteria
of the study, but still be able to perform maximal effort high velocity muscle
contractions. In our contact with participants for recruitment, adults with impaired
mobility tended to be less motivated to participate in research, and travel to/from
the hospital for testing was a barrier for many participants as their mobility was
compromised. Therefore, the people who are included in the mobility-impaired
group do not represent all older adults with mobility deficits and likely are at the
higher end of functioning of the mobility-impaired population. Therefore, finding
differences between healthy older adults and the mobility-impaired older adults will
be biased towards the null due to a reduction in the magnitude of difference
between the groups. As well, the healthy older adults recruited for this study were
highly active for their age, and were associated with a group exercise program.
Consequently, they may better represent a sample of “ideal aging” rather than a
typical aged person. Therefore, our mobility-impaired older adults may better
represent typical aging, while our healthy older adults might be representative of
very healthy and active aged women. Finally, due to the COVID-19 pandemic, the
recruitment process for mobility-impaired older adults had to be cut short as all
non-essential research activities were prohibited. Although a relatively small
sample size does affect the power of our analysis, previous works have been able to
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demonstrate significant results with a similar sample size using DE-STA [9, 20-22],
MRI [23, 24] and strength/power analysis [9, 25].
The present studies are also limited by their cross-sectional design, which
limits the ability to assign temporal order to the findings. Further longitudinal
studies, which have the advantage of showing true change in an individual over
time, into the neuromuscular properties of mobility-impaired older adults are
warranted.
As all of the subjects in the present studies were females, the results can only
be generalized to females and may not necessarily represent older males with
mobility impairment. Previous research has shown that males and females differ in
muscle mass and strength loss with age, and although males tend to be stronger
than females, they also tend to lose a greater proportion of strength during
senescence [26, 27]. The decision to include only females in this study was
intentional in order to maintain a homogenous sample and maintain a high level of
internal validity. As well, most previous studies of neuromuscular properties in
older adults have focused on older men. By using similar techniques and study
design as these previous studies, we were able to draw a comparison to the
previously published data and present findings for a novel sample of older females.
Finally, including some additional standardized functional performance
measures (such as the SPPB) may have allowed for a more comprehensive
evaluation of our participants’ mobility and allowed for a better comparison to
previous studies [28, 29]. However, we did include many of the individual
components of the SPPB (i.e. gait speed, repeated chair stands) to categorize our
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older adults. As well, we evaluated all of the domains for the diagnosis of sarcopenia
(grip strength, gait speed, muscle mass) as specified by the European working group
consensus [19].
5.2 Future Directions
The results of these studies highlight some future directions for continued
research on aging and mobility. First, in Chapter 2 we found that the S-MUP negative
peak amplitude decreased from young, to older and mobility-impaired older adults
in the VM muscle. Similar results have been reported in previous studies with
quantitative EMG recordings of large proximal muscle such as the VM [30, 31],
despite this being contrary to the established model of denervation and
reinnervation with aging where surviving motor neurons sprout collateral axons to
reinnervate lost fibers, thereby growing their MU size and associated S-MUP. It has
been reported that surface electrodes may be unable to accurately reflect MUs in
larger proximal muscles [9, 32] with an estimated recoding radius of only 20mm
[33]. As well, the accumulation of IMAT and subcutaneous fats in older adults may
attenuate the EMG signal [26, 34, 35]. Therefore, future research should investigate
novel techniques to accurately measure MU loss and neuromuscular remodeling in
large proximal muscles, especially considering their significance to functional
mobility tasks. In theory NF jiggle is one technique that may be able to accomplish
this task, as the high-pass filter emphasizes the contribution of only muscle fibers
closest to the concentric needle electrode, eliminating the potential error of the
more spatially distributed MUs in larger muscles. However, there is limited data
available on NF jiggle, and the results are not always in agreement with the data
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presented here [30]. More research is required to collect normative data on NF
jiggle across different age groups and adults with different levels of functional
performance.
Additionally, when comparing our results in Chapter 2 to previously
published data, our MUNEs were higher across all groups tested. While our sample
consisted of entirely females, most previous studies contained only male
participants. Given the documented neuroprotective effects of estrogen [36, 37], and
the fact that females characterize a larger proportion of the aged population [38],
further research comparing sex differences in neuromuscular properties with aging
is warranted.
Results from Chapter 3 indicate a further need for studies investigating MTR
in aged muscle. Although we observed a decline in MTR in both older groups
compared to young, healthy older adults actually had a further decline in MTR
compared to mobility-impaired adults, which we suggested may be related to poor
quality MUs in healthy adults who are undergoing cycles of denervation and
reinnervation. Thus, future studies should focus on muscle quality at difference
stages of sarcopenia such as those put forth by the European working group [19] to
help delineate the changes in MTR in muscle at different ages and levels of function
and mobility.
In Chapter 4 we observed that mobility-impaired older adults were unable to
maintain relative contraction velocity as the isotonic load increased, leading to a
greater reduction in muscular power at higher loads. Recent work has emphasized
high velocity power training as a potential substitute for conventional strength
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training to better improve overall functional performance in older adults [15, 39].
Results from this study further validate the need for studies of high velocity power
training, specifically longitudinal studies investigating older adults with different
levels of functional mobility. As well, considering most previous studies of mobilityimpaired older adults consisted of a much older population [28, 29], further
longitudinal investigations into how the older adults in this study with early onset
mobility impairment progress with advanced age is warranted. Finally, though it has
been identified that reduced contraction velocity is the critical component leading to
muscular power loss with age, the precise intrinsic mechanisms by which
contraction velocity is lost have not been identified and require further
investigation.
5.3 Summary
In summary, this series of studies was designed to identify the changes to the
neuromuscular system in a group of older adults with mobility impairment
compared to healthy age-matched and young adults. To our knowledge, these are
the first studies to investigate these measures in a group of older adults with poor
functional performance who were similar in age to a group of healthy older adults.
The results of this investigation demonstrate that mobility-impaired older adults
had greater MU loss, as well as significantly reduced contraction velocity in their
lower extremity muscles when compared to similarly aged healthy adults. These
studies provide novel insights into the aging neuromuscular system, and how it
translates into functional performance in older adults and further validates the use
of mobility and functional performance outcome measures in the description and
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classification of sarcopenia. Moreover, it emphasizes that mobility and performance
are not simply a matter of preserved muscle mass, but are related to altered
intrinsic force generating capacity of individual muscle fibers with advanced age.
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